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RESUMO 
O cérebro é uma estrutura complexa formada por inúmeras células com diversas formas 
e funções, nomeadamente neurónios e células da glia, que incluem astrócitos, 
oligodendrócitos e microglia. No caso dos neurónios, estes divergem num grande número de 
subtipos, com base em características moleculares, morfológicas e electrofisiológicas. São 
células especializadas na transmissão e integração da informação, sendo que para tal, a sua 
morfologia é essencial. Para além do corpo celular, são normalmente formados por dois tipos 
diferentes de processos especializados, inúmeras dendrites, que recebem e levam a 
informação para o corpo celular, e um único axónio, que leva a informação para fora do corpo 
celular. Deste modo, o desenvolvimento de uma morfologia especializada e a expressão de 
moléculas específicas durante a diferenciação e maturação neuronal, constituem eventos 
essenciais à formação de neurónios maduros funcionais. O ambiente neural influencia 
grandemente a diferenciação. Os neurónios em diferenciação e maturação estão sujeitos à 
acção do meio envolvente, de moléculas sinalizadoras, as chamadas “pistas de orientação” (do 
inglês, signalling cues), que são libertadas pelas células vizinhas, induzindo alterações 
morfológicas nos primeiros. A existência de estruturas especializadas nas extremidades dos 
processos em desenvolvimento, os cones de crescimento, a partir dos quais os processos 
crescem, é fundamental para conduzir os processos em crescimento para um local específico, 
em resposta às pistas de orientação no meio extracelular, de modo a estabelecer contactos 
com outros neurónios. Deste modo, a maior alteração nas células nervosas durante o seu 
desenvolvimento é o crescimento extensivo de axónios e dendrites, bem como a proliferação 
de sinapses. Um exemplo conhecido de uma molécula sinalizadora que influencia a 
diferenciação e maturação neuronal é o factor neurotrófico derivado do cérebro, BDNF (do 
inglês, brain-derived neurotrophic factor). As suas acções estendem-se também à 
sobrevivência neuronal, bem como à modulação da transmissão e plasticidade sináptica. Para 
executar estas acções, o BDNF liga-se a dois tipos de receptores, nomeadamente aos 
receptores de alta afinidade de tirosina cinase, TrkB (do inglês, tropomyosin-related kinase B), 
e aos receptores de baixa afinidade, pertencentes à superfamília dos receptores do factor de 
necrose tumoral, p75NTR (do inglês, p75 neurotrophin receptor). A nível da maturação 
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neuronal, o BDNF dá origem a alterações estruturais na célula, tais como a indução de 
dendrites primárias e arborização axonal e dendrítica, uma acção que envolve activação de 
cascatas de sinalização, como as vias das cinases PI3K (do inglês, phosphatidylinositol 3-
kinase), a MAPK (do inglês, mitogen-activated protein kinase) e, com menor importância, a 
PLC (do inglês, phospholipase C) A adenosina é um neuromodulador do sistema nervoso 
central, partilhando com o BDNF funções moduladoras da actividade sináptica. É o caso da 
facilitação das acções sinápticas do BDNF através da co-activação dos receptores A2A da 
adenosina, os quais estão acoplados à formação de cAMP, com consequente activação da 
proteína cinase A (PKA, do inglês, protein kinase A). Dada esta interacção entre ambos 
receptores, foi colocada a hipótese de que a adenosina, por activação dos receptores A2A, 
influencia as acções tróficas do BDNF na maturação neuronal. 
O objectivo do trabalho descrito nesta tese foi avaliar se os receptores A2A da adenosina 
modulam as acções tróficas do BDNF na maturação neuronal. Para além disso, também foi 
estudada a importância da adenosina endógena na activação dos receptores A2A e TrkB. 
Finalmente, foram exploradas as potenciais vias de sinalização associadas às acções tróficas 
dos receptores A2A na maturação neuronal. Para tal, recorreu-se à utilização de um software 
de medição de características morfológicas, HCA-Vision, o qual, a partir de uma imagem de um 
neurónio obtida por microscopia de fluorescência, cria um neurónio virtual, através do qual é 
possível realizar medições morfométricas, tais como o comprimento total das neurites e da 
neurite máxima, bem como o número de neurites primárias e de pontos de ramificação. 
Ao terceiro dia de cultura, neurónios corticais foram pré-incubados na presença ou 
ausência do agonista selectivo dos receptores A2A da adenosina, CGS 21680 (10nM), e/ou do 
antagonista desse receptor, ZM 241385 (50nM), sendo 20 minutos depois incubados com 
BDNF (20ng/mL). As culturas ficaram a incubar a 37˚C numa atmosfera humidificada com 5% 
CO2, com os ligandos anteriormente descritos até serem fixadas ao sétimo dia. Através da 
técnica de imunocitoquímica, os neurónios foram marcados para a proteína de ligação aos 
microtúbulos MAP2 (do inglês, microtubule-associated protein 2), com um fluoróforo 
conjugado com um anticorpo anti-MAP2, e o núcleo celular, com o marcador nuclear DAPI, 
que se liga ao DNA (do inglês, deoxyribonucleic acid). Observou-se que, tanto o BDNF como a 
activação dos receptores A2A da adenosina modulam a morfogénese neuronal, no entanto 
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com efeitos distintos. O BDNF induz a formação de dendrites primárias, enquanto que a 
activação dos receptores da adenosina promovem um crescimento da neurite máxima. Para 
além disso, ambos induziram um aumento do número de pontos de ramificação. No caso da 
formação de dendrites primárias, estas mostraram ser independentes da activação dos 
receptores A2A da adenosina, contudo, os resultados obtidos levam a sugerir uma possível 
modulação deste receptor nos efeitos do BDNF na arborização dendrítica. Para além disso, a 
utilização de um antagonista selectivo para o receptor A2A permitiu observar uma diminuição 
do tamanho da neurite máxima e número de pontos de ramificação na ausência de ligandos 
activadores dos receptores em estudo, sugerindo uma actividade basal dos receptores A2A 
com consequências para a maturação neuronal. 
Para além disso, dado que no meio extracelular existem sempre quantidades 
consideráveis de adenosina, que é libertada tanto por neurónios como por células da glia, ou 
mesmo sintetizada extracelularmente por acção de ectoenzimas, fui explorar se a adenosina 
endógena, presente no meio de cultura, seria importante nos efeitos tónicos e basais dos 
receptores A2A e TrkB. Para tal, neurónios corticais em cultura foram tratados com adenosina 
desaminase (ADA, do inglês adenosine deaminase) 1h antes da adição dos ligandos dos 
receptores TrkB e A2A. Estes ficaram a incubar até serem fixados ao sétimo dia de cultura, 
sendo de seguida marcados para o MAP2 e núcleo. A remoção da adenosina endógena do 
meio extracelular pela utilização de ADA, não afectou a acção dos receptores A2A, no entanto 
atenuou o efeito do BDNF no aumento do número de pontos de ramificação e de neurites 
primárias. No primeiro caso, apesar de se já ter observado uma activação tónica dos 
receptores A2A (resultados com o antagonista A2A), a ausência de efeito aquando da remoção 
da adenosina endógena, sugere a presença de um outro receptor de adenosina com uma 
função oposta à dos A2A. No caso do BDNF, a atenuação dos seus efeitos na maturação 
neuronal pela remoção da adenosina extracelular, mas não pelo antagonista A2A, sugere 
novamente o envolvimento de um outro receptor de adenosina. 
Finalmente, foi-se explorar as vias de sinalização activadas aquando das acções tróficas 
dos receptores A2A da adenosina na maturação neuronal. Para tal, experiências com inibidores 
farmacológicos foram realizadas ao terceiro dia de cultura. As vias de sinalização PI3K, MAPK, 
PLC e PKA foram bloqueadas através da incubação de neurónios corticais com, 
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respectivamente, os inibidores LY294002 (50μM), U0126 (10μM), U73122 (5μM) e Rp-cAMPS 
(100μM), os quais foram adicionados 30 minutos antes da adição do agonista dos receptores 
A2A, permanecendo durante mais 5h em contacto com as células. Observou-se que o 
crescimento da neurite máxima, promovido pela activação dos receptores A2A, foi 
completamente prevenido pelo bloqueio das vias de sinalização PI3K e MAPK e PLC; por 
outro lado, o aumento do número de pontos de ramificação por activação dos receptores A2A 
foi prevenido pelo bloqueio da PI3K, MAPK e PKA. 
Em conclusão, os resultados deste trabalho demonstram que tanto a activação dos 
receptores TrkB e A2A têm efeitos na maturação neuronal. Enquanto o primeiro promove a 
formação de dendrites primárias, o segundo promove o crescimento da neurite máxima, 
sendo que ambos apresentam uma acção coincidente na arborização dendrítica. Em estádios 
mais precoces da diferenciação neuronal, parece haver uma independência entre as acções 
tróficas do BDNF e as dos receptores A2A da adenosina, pois o aumento do número de 
dendrites primárias induzido pelo BDNF não é modulado pela activação, nem pela inibição, 
dos receptores A2A da adenosina. No entanto, ao longo do processo de maturação neuronal, 
as funções do BDNF parecem começar a ser moduladas pelo receptor A2A, como é o caso da 
arborização dendrítica. Para além disso, apesar da formação de neurites primárias não ser 
modulada pelo receptor A2A, parece ser modulada por um outro receptor de adenosina, tal 
como os restantes parâmetros morfológicos estudados. Finalmente, a acção trófica da 
adenosina, via activação dos receptores A2A, no crescimento da neurite máxima e na 
arborização dendrítica, mostrou ser dependente das vias de sinalização PI3K, MAPK, sendo a 
primeira também dependente da PLC e a segunda da PKA. 
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ABSTRACT 
BDNF is known to induce the formation of primary dendrites in cortical neurons via PI3K 
and MAPK pathways. Adenosine, through A2A receptors (A2ARs), facilitates BDNF synaptic 
actions, but it is not known if this extends to BDNF influence upon neuronal maturation. Since 
the effects of BDNF are dependent on cAMP formation and A2ARs are coupled to the AC/cAMP 
transducing system, I tested the hypothesis that adenosine, through A2AR activation, was able 
to modulate BDNF actions upon neuronal maturation. 
E18 forebrain neurons from Sprague-Dawley rats were seeded at 104cells/cm2, and 
treated, at DIC 3, with CGS21680 (10-100nM) and/or ZM241385 (50nM) 20 minutes before 
BDNF (20ng/mL), remaining there until DIC 7. Cells stained with anti-MAP2 and DAPI were 
analysed by HCA-Vision software in terms of maximal neurite length and number of roots and 
branch points. The A2AR agonist, CGS21680, increased maximal neurite length, and the 
number of branch points in a concentration-dependent manner, with maximal effect at 30nM. 
BDNF increased the number of roots and branch points. The effect of BDNF upon neuronal 
branching was modified by CGS21680 or by ZM241385. The effects of BDNF upon the number 
of roots were not influenced by CGS21680, but it was attenuated by endogenous adenosine 
removal with adenosine deaminase. To address the signalling pathways activated by A2AR 
upon neuronal maturation, neurons were treated, at DIC 3, with inhibitors of PI3K, MAPK, 
PLC and PKA signalling pathways 30 minutes before the addition of CGS21680, which 
remained in the medium for 5h until fixation. The effects of the A2AR agonist were totally 
prevented by blocking PI3K and MAPK pathways; blocking PLC prevented the influence of the 
A2AR agonist upon maximal neurite elongation, whereas PKA blockade prevented its influence 
upon dendritic branching. 
These results suggest that A2ARs are involved in neurite elongation, while BDNF 
influences new primary dendrites formation, being that both receptors operate independently 
at early stages of neuronal maturation. However, they seem to crosstalk at later stages. 
Endogenous adenosine seems to influence BDNF-induced formation of roots, a process that 
might involve other adenosine receptors. Finally, the signalling pathways involved in the A2AR 
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actions upon neural maturation require PI3K, MAPK and PLC signalling pathways for maximal 
neurite elongation and PI3K, MAPK and PKA for branching. 
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ABBREVIATION LIST 
A2AR – adenosine A2A receptor 
ADA – adenosine deaminase 
AMP – adenosine 5’-monophosphate 
cAMP – 3’,5’-cyclic AMP 
ATP – adenosine 5’-triphosphate 
BDNF – brain-derived neurotrophic factor 
BSA – bovine serum albumin 
CGS 21680 – 4-[2-[[6-Amino-9-(N-ethyl-b-D-ribofuranuronamidosyl)-9H-purin-2-yl]amino] 
ethyl]-benzene propanoic acid hydrochloride  
CNS – central nervous system 
CREB – cAMP-response element binding protein 
DAPI – 4’, 6’-diamidino-2-phenylindole 
DIC – days in culture 
ECL – enhanced chemiluminescencent 
ERK – extracellular signal-regulated protein kinases 
GAPDH – glyceraldehyde-3-phosphate dehydrogenase 
GPCR – G-protein coupled receptor 
HBSS – Hank’s balanced salt solution 
HRP – horseradish peroxidase 
LY294002 – 2-(4-Morpholinyl)-8-phenyl-1(4H)-benzopyran-4-one 
MAP – microtubule-associated protein 
MAPK – mitogen-activated protein kinase 
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mRNA – messenger ribonucleic acid 
NGF – nerve growth factor 
P75NTR – p75 neurotrophin receptor 
PBS – phosphate-buffered saline 
PFA – paraformaldehyde 
PI3K – phosphatidylinositol 3-kinase 
PKA – protein kinase A 
PKC – protein kinase C 
PLC – phospholipase C 
PVDF – polyvinylidene fluoride 
RGC – radial glial cell 
Rp-cAMPS – Rp-Adenosine 3’,5’-cyclic monophosphorothioate triethylammonium salt hydrate 
SDS  – sodium dodecyl sulphate 
TBS – tris-buffered saline 
Tris – tris-hydroxymethyl-aminomethane 
Trk – Tropomyosin-related kinase 
U0126 – 1,4-Diamino-2,3-dicyano-1,4-bis(2-aminophenylthio)butadiene 
U73122 –1-[6-[[(17b)-3-Methoxyestra-1,3,5(10)-trien-17-yl]amino]hexyl]-1H-pyrrole-2,5-dione 
ZM 241385 – 4-(2-[7-Amino-2-(2-furyl)[1,2,4]triazolo[2,3-a][1,3,5]triazin-5-ylamino]ethyl) 
phenol 
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1 INTRODUCTION 
The mammalian neocortex is a remarkably complex structure. In the case of the human, 
the neocortex exists as its most complex and evolved state, as it is the region of the brain that 
is responsible for higher functions such as sensation, action, cognition, thoughts, memories, 
language and consciousness. Thus, it corresponds to the part of the brain that most 
distinguishes humans from the rest of the species. Neocortex is composed by two major 
neuronal cell types, excitatory pyramidal neurons and inhibitory interneurons, and glial cells 
such as astrocytes, oligodendrocytes, and microglial cells, establishing rich local and external 
connections, i.e. synapses, with other regions of the central nervous system. Both neuronal 
subtypes diverge in a large number of subtypes, each of which possessing distinct molecular, 
morphological, and electrophysiological characteristics. Nonetheless, despite such cell type 
heterogeneity, cortical neurons display an extraordinary laminar organization since their cell 
bodies are distributed into six distinct layers along the radial axis of neocortex. This orderly 
cortical laminar organization provides key advantages for the processing and storage of neural 
information in the cerebral cortex. 
The formation of a functional neuronal network in the cerebral cortex, as we know in the 
adult brain, is dependent on the coordination of two high organized cellular processes, such as 
neuronal migration and neuronal maturation. Therefore, the unravelling of the early 
development of this complex structure that is the cerebral cortex might provide the key to 
understand the mechanisms underlying the pathogenesis of many cognitive disorders. 
1.1 Corticogenesis 
During embryonic development, the vast majority of neurons of the cerebral cortex are 
generated from precursor cells that are located in a pseudostratified epithelial cell layer which 
surrounds the early ventricular lumen. This neuroepithelial cell layer is composed by two 
distinct germinal zones: the ventricular zone and the subventricular zone. The ventricular zone 
corresponds to the innermost neuroepithelial cell layer of progenitor cells that adjacently 
surrounds the lumen of the neural tube that lines the lateral ventricles, and the subventricular 
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zone lies superficially on the ventricular zone (see Diaz and Gleeson, 2009). The 
neuroepithelial progenitor cells in the germinal zones have a high mitotic activity in order to 
maintain its progenitor population and produce radial glial cells (RGC), which retain contact 
with both ventrical and pial surfaces. Cortical neurons are generated from asymmetric division 
of RGSs (Anthony et al., 2004) to produce one proliferative glial cell that stays in germinal zone 
and one neuron that migrates towards the pial surface to the cortical plate, through a 
migratory process guided by RGSs (see Huang, 2009). Within the cortical plate, neurons 
become organized into well-defined layers, being known six layers in the mammalian 
neocortex. The layering of neurons in the cerebral cortex is established in an inside-first, 
outside-last manner. In other words, the cells that migrate from the ventricular zone and leave 
the cell cycle at early stages give rise to neurons that form the deepest layers of the cortex, 
while cells that leave the ventricular zone and exit the cell cycle at progressively later stages 
migrate over longer distances, pass early-born neurons, and settle in more superficial layers of 
the cortex, forming the more superficial layers of the neocortex (Sidman and Rakic, 1973; 
Rakic, 1988; Marin-Padilla, 1998; Molnar et al., 2006; Abdel-Mannan et al., 2008). 
Nevertheless, besides the majority of neurons originate in the local neuroepithelium, recent 
studies have revealed that some neurons, such as Cajal-Retzius cells (Bielle et al., 2005), 
cortical interneurons and cortical predecessor neurons, have different origins and complex 
migratory routes (Bystron et al., 2006; Bystron et al., 2008). 
1.2 Neuronal Interaction with its surrounding Environment 
Neurons are polarized cells, formed by two distinct types of processes, typically a single 
axon and multiple dendrites, which allow them to receive, process and transmit information in 
a single direction. During the period of migration, from the germinal zone to the cortical plate, 
neurons have just a simple bipolar form, which is very different from their more complex adult 
morphology. Many specialized biochemical properties, such as neurotransmitters, crucial for a 
mature neuron to participate in neuronal circuits, are not yet expressed in the cells. So, 
besides neurons may be in the correct place, when they arrive to the cortical plate, the 
dendritic trees are hardly formed, as well as many axons have yet to find their correct 
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destination. As a result, it is in the cortical plate that cortical neurons begin their final 
differentiation into a functional mature form, through the formation of a distinct axon and a 
dendritic arborization, together with the expression of specific molecules important to the 
establishment of functional synapses. 
Experiments using cultured embryonic neurons have revealed that neurons initially 
generate several equivalent neurites and begin to polarize when one neurite becomes an 
axon, with the other neurites, lately, becoming dendrites. Dotti et al. (1988), in cultured 
hippocampal neurons, observed this differentiation process and divided the morphological 
events into five stages (Figure 1.1). Dotti and co-workers demonstrated that shortly after 
plating, neuronal development starts with round spheres that spread lamellipodia around the 
cell body (stage 1). Then, these protrusions develop into several short immature neurites, 
which contain dynamic growth cones at their tips (12-24h; stage 2). Neurites, at this early 
developmental stage, alternate phases of elongation and retraction and are approximately 
equal in length, being, consequently, unpolarized cells. Neuronal polarization occurs when one 
of these equally long neurites starts to grow rapidly to become the axon (24-48h; stage 3). A 
few days after the formation of the axon, the remaining neurites slowly elongate to become 
dendrites (> 3-4 days; stage 4). The axon and dendrites continue to mature, expressing specific 
proteins very important to the formation of synaptic contacts and establishment of a neuronal 
network with the formation of dendritic spines and filopodia (> 1 week in culture; stage 5) 
(Dotti et al., 1988). 
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Figure 1.1 Processes of neuronal differentiation in cultured hippocampal neurons. Cultured hippocampal 
neurons from rodent hippocampus acquire their characteristic polarized morphology in five well-defined 
stages (From Yoshimura et al., 2006). 
However, in vivo, neuronal differentiation and maturation is more complicated than in 
cultures, as neurons are involved by the complex environment existent in the brain, i.e. 
neurons have to extend axons over great distances bypassing billions of potential synaptic 
targets before reaching the correct area and recognizing the appropriate targets. Though, 
these pathways along which axons grow provide a large number of diverse molecular cues 
that are crucial to guide axons to their targets, as axons possess specific receptors to recognize 
and interpret these cues. By sensing the extracellular cues, signalling cascades are activated 
and the growth cone at the tip of the axon steers towards (attractants) or away (repellents) 
from them, through changes in cytoskeleton organization. Given the great distance that can 
separate growth cones from their cell bodies, axon pathfinding presents a challenge to 
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neurons in ensuring that growth cones respond properly and rapidly to complex extracellular 
stimuli encountered along the way. Classically, it has been thought that the proteins required 
for directional steering originate in cell bodies, where they are synthesized and subsequently 
transported to growth cones to mediate responses to extracellular stimuli. However, recent 
evidence suggests that the functional autonomy seen in axonal growth cones is mediated by 
local protein synthesis. According to this view, subsets of neuronal mRNAs are trafficked into 
axons and growth cones, and different guidance cues elicit translation of a distinct set of 
proteins in a spatially restricted manner, being locally translated independently of cell bodies. 
In the case of dendrites, local translation of mRNAs is now relatively well characterized and is 
critically important for synaptic plasticity and memory. Some of the axonal mRNAs known in 
vertebrate central nervous system (CNS) include cytoskeletal proteins, such as β-actin, β-
tubulin, microtubule-associated protein 1b (MAP1b), tau, and neurofilament, as well as 
proteins involved in cytoskeleton remodelling, as actin depolymerizing factor ADF/cofilin, a 
protein involved in cytoskeleton disassembly. Other mRNAs present encode other functional 
proteins that include cell signalling molecules, transcription factors like cAMP-response 
element binding (CREB) protein and transmembrane receptors. This suggests that axons, and 
in a similar way dendrites, contain a diverse repertoire of mRNAs that can be potentially 
translated, enabling a neuron to rapidly respond to the extracellular environment, by 
translating specific subsets of proteins that will induce cytoskeletal reorganization (for a 
review see Tahirovic and Bradke, 2009). 
All these processes of neurogenesis, neuronal migration and maturation, during the 
development of the cerebral cortex, are enabled by the dynamic regulation of the cytoskeletal 
machinery in response to extracellular guidance or positional cues, factors that are released 
from the surrounding cells, including neighbouring and distant neurons and glial cells. An 
example of extracellular guidance cues are neurotrophins.  
1.3 Neurotrophins 
During the process of the embryonic development of the nervous system there is an 
overproduction of neurons, and glial cells, followed by the programmed death of superfluous 
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cells, which is now known to occur in almost all regions of the central and peripheral nervous 
systems. It was Hamburger and Levi-Montalcini who developed the neurotrophic factor 
hypothesis, the idea that the target cells of developing neurons have a critical role in 
regulating the number of surviving neurons, by producing a limited amount of an essential 
nutrient or trophic factor that is taken up by the nerve terminals. Based on this hypothesis 
neurons extend axons to the vicinity of target cells which secrete limited amounts of 
neurotrophic factors that bind to specific receptors localized on the surface of nerve 
terminals. Neurons that do not receive adequate amounts of neurotrophic factor die by 
apoptosis, while the others survive. Following this hypothesis, Levi-Montalcini and Stanley 
Cohen isolated nerve growth factor (NGF), the first neurotrophic factor to be identified by 
isolating it from snake venom, which provided the first direct support for the neurotrophic 
hypothesis (Cohen et al., 1954; Cohen and Levi-Montalcini, 1956). NGF is one of a large array 
of secreted factors that have the ability to promote the survival of neurons. Apart from NGF, 
there are three more major neurotrophins that have been isolated from mammals which are 
brain-derived neurotrophic factor (BDNF), neurotrophin 3 (NT3), and neurotrophin 4/5 (NT4,5) 
(see Huang and Reichardt, 2001; Chao, 2003). 
These neurotrophins interact with two types of transmembranar cell surface receptors: 
the high affinity tropomyosin-related kinase receptor (Trk), a receptor that belongs to the 
tyrosine kinase family of receptors; and the pan-neurotrophin receptor p75NTR, which belongs 
to the tumor necrosis factor receptor family. Neurotrophic factors were originally believed to 
promote the survival of neural cells by stimulating their metabolism in beneficial ways. 
Instead, it now appears that such factors act predominantly by suppressing a latent 
biochemical pathway present in all cells of the body. This biochemical pathway is a suicide 
program, induced by the activation of p75NTR. Once activated it kills cells by apoptosis. The 
binding of neurotrophic factors to their tyrosine kinase receptors is thought to promote anti-
apoptotic Bcl-2-like activities or inhibit caspase activity (see Kaplan and Miller, 2000). Apart 
from that, neurotrophin-mediated activation of Trk receptors leads to a variety of biological 
responses, which includes proliferation, axonal and dendritic growth, guidance and 
remodelling, assembly and remodelling of cytoskeleton, membrane-trafficking, and 
modulation of synaptic formation, transmission and plasticity. In the case of p75NTR, it 
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activates a distinct set of signalling pathways within cells that are in some instances synergistic 
and in other instances antagonistic to those activated by Trk receptors (Figure 1.2) (Huang and 
Reichardt, 2003).  
 
Figure 1.2 Neurotrophin receptors, Trk and p75
NTR
, and correspondent signal transducing pathways. Binding 
of neurotrophins to Trk triggers the activation of signalling cascadas, such as Ras, phosphatidylinositol 3-
kinase (PI3K), and phospholipase C (PLC) pathways, resulting in gene expression, neuronal survival and 
neurite outgrowth (From Chao, 2003). 
Trk family of tyrosine kinases are the major signal-transducing receptors and consist 
of three membrane tyrosine kinases named TrkA, TrkB and TrkC. NGF interacts selectively with 
TrkA, whereas BDNF and neurotrophin 4/5 interact primarily with TrkB. Neurotrophin 3 
activates TrkC and, to a lesser extent, TrkB and TrkA (Chao, 2003). On the other hand, 
neurotrophins also bind to p75NTR with a similar low affinity, although proneurotrophins, the 
precursors of the above mature neurotrophins, bind with high affinity to this class of receptors 
(Lee et al., 2001). 
Regarding neuronal differentiation and maturation, neurotrophins were reported to 
increase the dendritic complexity of pyramidal neurons by increasing total dendrite length, 
the number of branch points, and/or the number of primary dendrites (McAllister et al., 1995; 
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Baker et al., 1998; Niblock et al., 2000). Of the major signalling pathways activated by Trk 
receptors, the mitogen-activated protein kinase (MAPK) and phosphatidylinositol 3-kinase 
(PI3K) pathways have been implicated in neurite and dendrite filopodia formation in both 
neuronal cell lines and primary neurons (Posern et al., 2000; Wu et al., 2001). 
1.3.1 BDNF 
BDNF is a small, basic protein, with 252 amino acid residues, that was purified from 
the mammalian (pig) brain (Barde et al., 1982), being its actions the best characterized of the 
four neurotrophins in nervous system. BDNF levels are dynamically regulated in postnatal 
development, in part by activity-dependent mechanisms. BDNF is not synthesized as a mature 
protein, but as a precursor protein (preproBDNF) in endoplasmic reticulum. Upon cleavage of 
the signal peptide, proBDNF is formed, which is transported to the Golgi for sorting into either 
constitutive or regulated secretory vesicles. proBDNF can have functions by itself, being highly 
expressed, together with p75NTR, during a perinatal window when axonal outgrowth and 
synapse maturation is robust and having a more localized expression during 
adolescence/adulthood. ProBDNF may be converted into mature BDNF (mBDNF) 
intracellularly in the trans-Golgi or in the immature secretory granules (Chao and Bothwell, 
2002; Greenberg et al., 2009). 
This neurotrophin has several functions, such as promoting neuronal survival 
(Thoenen et al., 1987), modulating synaptic plasticity in learning and memory (Yamada and 
Nabeshima, 2003), facilitating neuromuscular activity (Boulanger and Poo, 1999; Pousinha et 
al., 2006), promoting neurogenesis during cortical development (Bartkowska et al., 2007), as 
well as regulating the growth and branching of dendrites and inducing the formation of new 
primary dendrites (Bartrup et al., 1997; Dijkhuizen and Ghosh, 2005). These actions of BDNF 
are possible through the activation of BDNF the above mentioned specific membrane receptor 
TrkB, to which BDNF binds with high affinity, inducing receptor dimerization and 
autophosphorylation in tyrosine residues in the cytoplasmic domain. These phosphorylated 
tyrosines promote the activation of multiple intracellular signalling pathways, by the 
recruitment of various adapter proteins, such as Src homologous and collagen-like (Shc) 
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adaptor protein, or phospholipase C (PLC). Shc adaptor protein links the activated Trk 
receptor to two separate intracellular signalling cascades, namely PI3K and Ras pathway that 
leads to activation of Akt and MAPK. In addition, PLC binds to activated Trk receptors and 
initiates an intracellular signalling cascade, resulting in the release of inositol phosphates, with 
consequent release of intracellular calcium (Ca2+), and activation of protein kinase C (PKC) 
(Figure 1.2) (Chao, 2003; Huang and Reichardt, 2003). The Ras and MAPK pathways have been 
more related to primarily stimulate processes responsible for neuronal differentiation, and 
PI3K pathway for cell survival, whereas PLC, is more associated with fast actions of BDNF, as 
it happens in synaptic activity. In the case of cultured cortical neurons, BDNF was reported to 
induce primary dendrite formation via activation of the PI3K and MAPK pathways with a minor 
role of PLC (Dijkhuizen and Ghosh, 2005). 
BDNF and TrkB receptors are highly expressed in the developing CNS during times of 
neuronal differentiation (McAllister et al., 1999). Depending on the alternative splicing, TrkB 
receptors can lead to the formation of truncated receptors, which lack most of the 
intracellular domain (Chao, 2003). In neocortex, full-length TrkB receptor is the major trkB 
form during early development, while truncated TrkB predominates in all forebrain regions of 
late postnatal and adult rats (Allendoerfer et al., 1994; Fryer et al., 1996). In cortical neurons, 
TrkB was shown to be present both in excitatory and inhibitory neurons, being that in 
excitatory ones, TrkB was found in all of the major neuronal compartments, namely in the cell 
body, dendrites and axons both at 4 and 10 days in culture, as well as in the surface of axonal 
growth cones and dendritic filopodia before synapse formation, which showed an increasingly 
localization to synapses through the development (Gomes et al., 2006). The presence of TrkB 
on the surface of growth cones and dendritic filopodia allows BDNF to activate local signalling 
pathways, playing thus a role in the BDNF-induced chemotropic responses. Guidance cues, 
such as BDNF, require local protein synthesis, to induce rapid cytoskeletal modifications, 
making it possible for growth cones to respond to chemo-attractants or repellents, by 
changing their pathways. An example of a protein recently reported, which is locally translated 
in response to BDNF signalling, is -actin, through the phosphorylation of zipcode-binding 
protein (ZBP) 1 by Src family kinases (SFKs) (Yao et al., 2006; Sasaki et al., 2010). In addition, 
activation of the PI3K activation was demonstrated to be involved in the modulation of 
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protein translation by regulating the phosphorylation of eukaryotic translation initiation factor 
(eIF) 4E, as well as MAPKs, such as p42/p44 MAPK which is involved in many aspects of cellular 
responses, including cell growth and differentiation. 
In neurons, the reorganization of the cytoskeleton by BDNF is a fundamental 
mechanism not only to initial stages of neuronal differentiation, such as regulate axon 
guidance, but also final stages regarding maturation and synaptic plasticity. Fast changes in 
synaptic efficacy may be translated into structural alterations when the synapses are exposed 
to BDNF for a longer period of time. These include axonal branching (Cohen-Cory and Fraser, 
1995; Gallo and Letourneau, 1998), dendritic growth and complexity (McAllister et al., 1995; 
McAllister et al., 1997; McAllister et al., 1999), and activity-dependent refinement of synapses 
and regulation of dendritic spine formation (Shimada et al., 1998). 
Because dendritic morphology determines the number, pattern, and types of synapses 
received by a neuron, regulation of cortical dendritic growth and branching by BDNF is likely 
to play a major role for the proper functioning of the brain, and especially the cerebral cortex. 
1.4 Adenosine 
Adenosine is a ubiquitous endogenous purine nucleoside that is released from most 
cells, including neurons and glia, and modulates many physiologic and biochemical processes 
in the brain. Due to its extremely short half-life, adenosine acts in a paracrine way, acting in 
the same cell or in the cells adjacent to the adenosine-releasing cell (Abbracchio and 
Cattabeni, 1999). Adenosine can be produced intracellularly and released through an 
equilibrative nucleoside transporter (ENT) (Thorn and Jarvis, 1996), or extracellularly by the 
hydrolysis of released adenine nucleotides, namely adenosine 5’-triphosphate (ATP), through 
the action of a cascade of ectoenzymes. Inactivation of extracellular adenosine predominantly 
occurs through reuptake, although deamination of extracellular adenosine to inosine or 
phosphorylation to 5’-monophosphate (5’-AMP) can also occur (Meijer et al., 2008). 
Adenosine is known to modulate neuronal activity, namely neurotransmitter release 
and its postsynaptic actions, as well as by nonsynaptically hyperpolarizing or depolarizing 
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neurons, thus regulating post-synaptic excitability. This nucleotide is also known to modulate 
the response of others receptors and neuromodulators (see Sebastião and Ribeiro, 2009). 
These actions mediated by adenosine are possible through the activation of four specific 
metabotropic G-protein coupled receptors (GPCRs), namely the A1, A2A, A2B and A3 subtypes. 
As A1 and A2A subtypes are considered to be high affinity receptors for adenosine, being that 
in basal conditions these subtype receptors are probably tonically activated, having 
physiological importance. On the other hand, the low affinity A2B and A3 receptors have more 
relevance in pathophysiological conditions, when the concentration of adenosine is higher, 
although in humans A3 subtype is a high affinity receptor (Ribeiro et al., 2003). GPCRs are 
seven-transmembrane domain receptors that are linked to a variety of transduction 
mechanisms. The main intracellular signalling pathways involve the formation of 3’,5’-cyclic 
AMP (cAMP), being A1 receptors mainly coupled to adenylate cyclase inhibitory G-proteins (Gi 
or Go), while A2A and A2B receptors to activation of adenylate cyclase stimulatory G-proteins 
(Gs), though coupling to PLC excitatory G-protein (Gq) can also occur. In the case of A3 
receptors, they are coupled to Gq and Gi (Fredholm et al., 2001a). 
Adenosine receptors are widely distributed through the brain, however depending on 
the brain area, age and cell sublocalization, there are differences in receptor expression. In the 
adult brain, the A1 receptor is highly expressed in cerebral cortex, cerebellum and 
hippocampus (Reppert et al., 1991; Rivkees et al., 1995; Svenningsson et al., 1997), while the 
others adenosine receptors are expressed in a more restricted way. A2A receptor is present in 
several brain areas, with a higher expression in the olfactory bulb and striatum (Jarvis and 
Williams, 1989), and at lower levels in the cerebral cortex (neocortex) and hippocampus 
(Cunha et al., 1994a; Kirk and Richardson, 1995; Svenningsson et al., 1997). Regarding A2B and 
A3 adenosine receptors, these have been demonstrated to be fairly dispersed through the 
brain, including the neocortex, although at very weak levels (Dixon et al., 1996; Fredholm et 
al., 2001a). Thus, due to its high expression in certain brain areas and to its high affinity, the 
neuromodulatory role of adenosine in the brain is mainly mediated by the balance between 
the inhibitory and excitatory actions of respectively adenosine A1 and A2A receptor actions. In 
contrast, the low expression and low affinity of A2B and A3 receptors may make these 
receptors relevant in pathophysiological conditions, when adenosine concentration greatly 
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increases, such as in ischemia and hypoxia (see Fredholm et al., 2001b; Borea et al., 2009). 
However the role of A2B and A3 receptors in the nervous system is much less understood (see 
Sebastião and Ribeiro, 2009). 
Regarding A2A receptor activation, adenosine is known to modulate neuronal activity, 
namely presynaptic neurotransmitter release and/or uptake, such as glutamate (Lopes et al., 
2002), gamma-aminobutyric acid (GABA) (Cunha and Ribeiro, 2000; Cristóvão-Ferreira et al., 
2009) or acetylcoline (Cunha et al., 1994b). Postsynaptic actions of A2A receptor activation are 
associated to the increase in long-term potentiation (LTP) and AMPA receptors expression in 
the postsynaptic membrane, through a PKA-dependent mechanism (Dias et al., 2010). Besides 
actions upon neuronal activity, there is evidence indicating that adenosine, acting through A2A 
receptors, may influence the development of the nervous system. It has been reported that 
A2A receptor is expressed in late prenatal periods and that their levels increase after birth. 
Although mRNA have reached their adult levels in neocortex, keeping nearly constant from 
embryonic day 18 (E18) onwards, protein receptor levels are low or undetectable at E18 and 
increase until postnatal day 14 (P14) (Adén et al., 2000). Moreover, A2A receptors in cortical 
cultured neurons were immunocytochemically demonstrated to be mainly present at nerve 
terminals after six days in culture (Rebola et al., 2005) and with less intensity in the cell body 
region (Lee et al., 2004). These time-dependent changes in A2A receptor expression in the 
brain, which have been reported during development, suggest a role in neuronal maturation. 
Recently, it has been reported that activation of A2A receptors can influence neurite 
outgrowth in PC12 cells (Heilbronn and Zimmermann, 1995; Cheng et al., 2002; Charles et al., 
2003). In PC12 cells endogenously expressing A2A receptors, antisense-mediated inactivation 
of the enzyme that converts AMP to adenosine, ecto-5’-nucleotidase, inhibits neurite 
outgrowth (Heilbronn and Zimmermann, 1995). In addition, A2A receptor activation 
counteracted the PD98059-induced blockade of NGF-induced neurite outgrowth, a process 
that involves MAPK and CREB activation (Cheng et al., 2002); and a bacterial nucleoside N6-
methyldeoxyadenosine (MDA) induces an A2A receptor-mediated neurite outgrowth in PC12 
cells which also depends on NGF-dependent MAPK activation (Charles et al., 2003). By the first 
time, Canals and co-workers explored the effect of direct activation of A2A receptors with their 
classical agonist, CGS 21680, in human neuroblastoma cell line SH-SY5Y and in primary 
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cultures of striatal neurons, showing that A2A receptor activation lead to neuritogenesis and 
differentiation, through a mechanism dependent on MAPK, PKC and PKA signalling pathways 
(Canals et al., 2005). 
1.5 Crosstalk between TrkB and Adenosine A 2A Receptors 
Apart from affecting nerve cells directly, adenosine, through A2A receptor activation, 
can also influence the action of neurotransmitters and other neuromodulators indirectly, 
which make adenosine to behave as a modulator of others modulators. These adenosine 
modulatory actions contribute to a very sophisticated crosstalk between its own receptors and 
the receptors for other neurotransmitters, neuromodulators or both (see Sebastião and 
Ribeiro, 2000). There are several possibilities for this crosstalk, such as at the transducing 
system level (Sebastião and Ribeiro, 2000) or even at the receptor level, as a consequence of 
receptor-receptor heteromerization (Ferré et al., 2007). 
There are evidences of a crosstalk between A2A and TrkB receptors, which has been 
carefully investigated in the hippocampus. For example, adenosine, acting through A2A 
receptor, can exert a trophic effect by transactivation TrkB receptor (Lee and Chao, 2001). A2A 
receptors control the facilitatory fast actions of BDNF at hippocampal synapses (Diógenes et 
al., 2004), with consequences for synaptic plasticity (Fontinha et al., 2008), trough a 
mechanism dependent on cAMP/PKA (Diógenes et al., 2004; Fontinha et al., 2008). In 
addition, A2A receptor presynaptically mediates the inhibition of A1 receptor actions upon the 
release of neurotransmitters, through a mechanism that involves PKC activity (Lopes et al., 
1999). Moreover, a crosstalk between A2A and TrkB receptors was also demonstrated at the 
neuromuscular junction where A2AR activation of the PKA pathway controls the action of 
BDNF, through the TrkB receptor (Pousinha et al., 2006). Hence, cAMP seems to be important 
for the signalling and biological functions of BDNF. On the other hand, regarding neuronal 
differentiation, it was demonstrated that growth cones of cultures of Xenopus spinal neurons 
and hippocampal neurons show either attractive or repulsive turning responses towards a 
gradient of BDNF, depending on the intracellular concentration of cAMP (Song et al., 1997; 
Mai et al., 2009). Other experiments suggested a ‘cAMP gating’ of TrkB phosphorylation and 
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cAMP regulation of TrkB trafficking to the postsynaptic densities (PSD), which may both 
contribute to the long-term regulation of dendritic spine formation by BDNF (Ji et al., 2005). 
Accordingly, as cAMP seems to be very important in BDNF functions upon neuronal 
maturation, I hypothesized that branching and formation of primary neurites mediated by 
BDNF could be influenced by the activation of A2A receptor. 
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2 OBJECTIVES 
The main goal of the present work was to unravel the actions of adenosine A2A receptor 
and BDNF upon neuronal maturation. To achieve this goal I: 
1. evaluated the actions of A2A receptors upon neuronal outgrowth, namely the length 
of neurites and neuronal branching; 
2. evaluated if A2A receptors modulate the actions of BDNF upon neuronal outgrowth; 
3. unravelled the transducing mechanisms involved in these actions. 
To pursue these objectives, cortical neurons from primary cultures were morphologically 
measured in terms of neurite length and number of primary neurites and branching. 
  
  
 
  
21 
3 METHODS 
3.1 Neuronal Cortical Cultures  
Cortical neurons were dissected from embryonic day 18 (E18) Sprague-Dawley 
embryos, obtained from Harlan Interfauna Iberia (Barcelona), as described by Vicario-Abejón 
(1997) and Assaife-Lopes et al. (2010), with minor modifications (Vicario-Abejón, 1997; 
Assaife-Lopes et al., 2010). Animals were handled according to the Portuguese law on Animal 
Care and European Union guidelines (86/609/EEC). 
Pregnant rats were anesthetized with halothane before being sacrificed by 
decapitation. Uterus containing embryos were rapidly removed from the rat abdomen and 
placed in Ca2+ and Mg2+ free HBSS (Hank’s Balanced Salt Solution) (supplied by Gibco) 
dissection medium supplemented with 0.37% glucose. Under sterile conditions, embryos were 
removed from the uterus and the brain was isolated by removing the skin and the skull of the 
embryo and by separating the ventral side of the brain from the rest of the head. Meninges 
and choroid plexus, which are highly vascularized, are removed very gently and then both 
hemispheres are opened so that the cortex can be removed. The whole dissection process was 
performed in cold HBSS medium previously referred. The cortices were trypsinized for 15 
minutes at 37˚C, in order to digest the proteins that facilitate adhesion between cells in the 
tissue. Following trypsinization, FBS (Fetal Bovine Serum) was added to quench trypsin activity 
and immediately after trypsin inhibition DNase was added to prevent the clumping of the 
tissue, since the effects of trypsinization and the DNA released from damaged cells can 
produce tissue clumping. The tissue was centrifuged 4 minutes at 188g at room temperature. 
The cortices were resuspended in Neurobasal medium (supplied by Gibco) supplemented with 
0.5mM glutamine, 2% B27 and 25U/mL penicillin/streptomycin, and cells were dissociated by 
passing the solution through a 10mL pipette 6-8 times and then through a yellow tip (20-
200μL) coupled to the pipette for 6-8 times. Cell suspension was filtered using a 70μm cell 
strainer to remove cell clumps. Then, cells were counted in a 75% trypan blue cellular solution 
using a Hemacytometer, and plated in poly-L-lysine-coated dishes at a low density of 
4x104cells/mL (Vallotton et al., 2007), in a 24-well plate (for morphometric analysis 
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experiments), and at a high density of 6x105cells/mL in a 85-mm plate, to measure the protein 
levels by western blot. The cortical primary cultures were incubated in an incubator with a 
humidified 37˚C and 5% CO2 atmosphere. After 3 days in culture (DIC 3), half of the medium 
was replaced by fresh Neurobasal medium supplemented as mentioned above. It is important 
just to change half of the medium because neurons are vulnerable to the adverse effects of 
changing medium, becoming more and more vulnerable as they differentiate. 
Dissociated cortical cultures were treated, at DIC 3 (Burkhalter et al., 2007), with the 
selective A2A receptor agonist CGS 21680 (10nM) (Diógenes et al., 2004) and/or the antagonist 
ZM 241385 (50nM) (Assaife-Lopes et al., 2010) 20 minutes before the TrkB endogenous ligand 
BDNF (20ng/mL) (Bartrup et al., 1997; Assaife-Lopes et al., 2010), and adenosine deaminase 
(ADA) (1U/mL) (Assaife-Lopes et al., 2010) was added 1h before BDNF or CGS 21680. When 
CGS 21680 was tested in the presence of ZM 241385, CGS 21680 was added 20 minutes after 
ZM 241385. All these ligands remained in the medium for a long term treatment until fixation 
at DIC 7. Experiments with inhibitors of transducing pathways were performed at DIC 3, in 
which inhibitors were added 30 minutes prior to the addition of BDNF or the agonist of A2A 
receptors, CGS 21680, remaining present until fixation 5h after the ligands addition 
(Dijkhuizen and Ghosh, 2005). The inhibitors used were LY294002 (a PI3K inhibitor), U73122 (a 
PLC inhibitor), U0126 (a MAP kinase kinase inhibitor) and Rp-cAMPS (a blocker of cAMP-
mediated effects) were used at a final concentration of 50µM, 5µM, 10µM and 100μM, 
respectively (Dijkhuizen and Ghosh, 2005; Lochner and Moolman, 2006; Assaife-Lopes et al., 
2010). 
The choice of DIC 3, as the time in culture to perform the treatment, results from the 
fact that at that time neurons were already polarized and are starting to form dendrites (Dotti 
et al., 1988). Consequently, receptors activation will be able to affect new dendrite formation 
as well as axon and dendrite development, without affecting neuronal polarization, i.e. the 
specification of the axon (Shelly et al., 2007). As neurons, at DIC 7, have already specified the 
axon and dendrites, as well as these processes have already started to branching and form 
filopodia (Dotti et al., 1988; Ziv and Smith, 1996), this time point of fixation was considered 
suitable to measure alterations in the neurite length, the number of primary neurites, and the 
number of branch points (see section 3.3). These morphological changes are important 
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measures for neuronal maturation, especially dendrite branching, as dendritic morphology 
determines the number, pattern, and types of synapses received by a neuron, being thus 
fundamental for the proper functioning of the brain. 
3.2 Immunocytochemistry 
DIC 3 and DIC 7 24-well plate cortical neurons were washed with Phosphate Buffer 
Saline (PBS) (NaCl 137mM, KCl 2.1mM, KH2PO4 1.8mM and Na2HPO4.2H2O 10mM, at pH=7.40), 
in order to remove the Neurobasal medium before fixation with 4% paraformaldehyde in PBS 
at room temperature, for 20 minutes. The cross-linking reagent paraformaldehyde was used 
to establish intermolecular bridges between free amino groups that make part of the cell 
structure, inducing a latticework of interactions that immobilizes the antigens, while retaining 
the cellular and subcellular architecture of the whole cell together. Excess of 
paraformaldehyde was removed by washing with PBS solution. As fixation with 
paraformaldehyde does not allow access of the antibody to the antigen, a permeabilization 
step was performed using a nonionic detergent, in which cultures were incubated for 10 
minutes in PBS containing 0.05% of the nonionic detergent Triton X-100 at room temperature, 
becoming possible for antibodies to penetrate inside the cell and bind to its specific antigen. 
This is followed by incubation with a blocking solution of PBS containing 0.25% gelatin for 30 
minutes, at room temperature. Gelatin is going to interact with other proteins as well as with 
the antibodies used, increasing the competition of antibodies in biding to their targets, with a 
consequent result of increasing selectivity to the antigen, decreasing the nonspecific binding. 
Cells were then incubated for 1h with the monoclonal primary antibody anti-MAP2 (1:200, 
Chemicon) in PBS containing 0.05% Tween 20 and 0.1% gelatin, where the detergent Tween 
20 facilitates penetration of the antibody as well as stabilizes it, and gelatin decreases 
antibody nonspecific binding. Extensive washes were then performed in PBS containing 0.05% 
Tween 20, in which Tween 20 interacts with the antibody and facilitate the remotion of 
unbouded and nonspecific bounded antibody. Cultures were incubated for 1h with a goat anti-
mouse secondary antibody conjugated to the fluorescent label Alexa Fluor 568 (1:500, 
Invitrogen) in PBS containing 0.05% Tween 20 and 0.1% gelatin. After more washes in PBS 
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containing 0.05% Tween 20, cultures were incubated for 5 minutes with DAPI (4’, 6’-
diamidino-2-phenylindole), which is a fluorescent stain that binds strongly to DNA, extensively 
used in fluorescence microscopy with maximum absorption at a wavelength of 358 nm 
(ultraviolet) and maximum emission at 461 nm (blue). Finally, after some washes with PBS 
containing 0.05% Tween 20 and a last wash with PBS to remove Tween from the sample, 
coverslips were mounted in Mowiol before visualization. Mowiol is a mounting media used for 
samples prepared for fluorescence microscopy because it is non-absorbing, contains no 
autofluorescence, or light scattering. 
3.3 Morphometric Analysis 
Detailed morphological analysis of neurons is crucial for studying the normal 
development of the dendritic and axonal arborization as well as the effect of drugs in the 
developing neurites. For that, images of neurons mounted in Mowiol were captured using a 
monochrome digital camera (AxioCamMR3, Zeiss) mounted on an inverted widefield 
fluorescence microscope (Zeiss Axiovert 200, Germany), with a 40x objective. As observed in 
Figure 3.1, the nuclear dye DAPI has a maximal absorption at 359nm and emission at 461nm, 
while Alexa Fluor 568 absorbs and emits at lower wavelengths with a maximum, respectively, 
at 578nm and 603nm. Thus, the filter sets (Figure 3.1) used were: a Zeiss filter set 15 
(Excitation filter BP 546/12; Beam splitter FT 580; Emission filter LP 590) to detect Alexa Fluor 
568 goat anti-mouse IgG antibody, in which allows to transmit light with a wavelength 
between 540-552nm and allows the transmission of wavelength greater than 590nM; and a 
Zeiss filter set 49 (Excitation filter G 365; Beam splitter FT 395; Emission filter BP 445/50) to 
detect DAPI bound to DNA. 
Images were captured using the software AxioVision 4 (Carl Zeiss Imaging Systems). The 
pixel size in the object space was 0.25μm and the captured images (Figure 3.2) were 1400 x 
1050 pixels size. Images were stored in uncompressed 8-bit Tiff format, each containing two 
channels, one with the representation of cellular nucleus, obtained with filter set 49 (Figure 
3.2 DAPI), and other channel with the cellular structure, obtained with filter set 15 (Figure 3.2 
Methods 
 
 
25 
MAP2). Images were analysed, in terms of neuronal morphometrics, using HCA-Vision 
software (CSIRO). 
 
Figure 3.1 – Absorption (dashed line) and fluorescence emission (continuous line) spectra of the fluorophores 
DAPI bound to DNA (blue) and Alexa Fluor 568 goat anti-mouse IgG antibody (green). The shading represents 
the excitation and emission intervals of the filter sets: Zeiss filter set 49, with excitation wavelength centred at 
365 nm (G 365) and emission between 420-470 nm (BP 445/50); and Zeiss filter set 15, with excitation 
wavelength between 540-552 nm (BP 446/12) and emission greater than 590 nm (LP 590). 
 
Figure 3.2 – Representative images of a control condition of cortical neurons with 7 days in culture. E18 rat 
primary cultures of cortical neurons were plated at 4x10
4
cells/mL. At DIC 7, cultures were fixed and 
immunostained for microtubule-associated protein 2 (1/200 antibody dilution), MAP2, and with the DAPI 
nuclear stain (blue). Staining with anti-MAP2 antibody was revealed by Alexa Fluor 568 (red) labelled goat 
anti-mouse antibody (1/500 dilution). Images were taken with an inverted widefield fluorescence microscope 
(Zeiss Axiovert 200, Germany), with a 40x objective, and using the Zeiss filter sets 49 and 15 for detection of 
DAPI and Alexa Fluor 568 antibody conjugated, respectively. 
HCA-Vision software has a module for Neurite Outgrowth which is a powerful tool for 
the analysis of neurite structure in fluorescence images. Through HCA-Vision it is possible to 
BP 445/50 BP 446/12 LP 590G 365
DAPI MAP2 MERGED
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analyse images in a fully automated manner regarding the segmentation of neuron bodies and 
neurites. For that, Neurite analysis is divided into three steps (Figure 3.2), including cell body 
detection, neurite detection, and neurite analysis, and optimal parameters of each wizard 
have to be chosen by the user, so that the software can generate neurite traces, segment the 
cell soma and associate neurites with their respective soma, with a consequent report of a 
virtual image of each neuron. In the cell body detection step, the images of the neurons 
stained with MAP2 are treated to suppress the noise, background corrected, and cell bodies 
are identified, as well as cell debris are eliminated based on their small size. Then, the second 
step is neurite detection, in which linear features are identified by classifying pixels as 
belonging to a linear feature based on its intensity. Pixels with high intensity are connected 
and the connected components smaller than a user defined threshold are removed. Gaps in 
the skeleton are closed. Finally, neurite analysis step, apart from removing very short lateral 
branches that result from thinning artifacts, combines the result of the cell body detection and 
of the neurite detection to produce a virtual image of the neuronal cell. With this virtual image 
it will be possible for the software to make quantitative measurements and statistics 
biologically relevant which are reported on a per-cell basis (Vallotton et al., 2007). Some of the 
quantitative measurements with morphological importance upon neurite outgrowth are the 
total neurite length, maximum neurite length, the number of branch points, and the number 
of roots (Figure 3.4 and Figure 3.5). 
To study neuronal morphometrics, the neuronal marker used was the antibody against 
MAP2, which labels dendrites (Bernhardt and Matus, 1984; Caceres et al., 1984). As no tau 
staining was used, it would be expected that axons were not taken into account (Binder et al., 
1985). However, MAP2 staining is also able to label axons until DIC 7, although very weakly 
(Caceres et al., 1986). Nevertheless, despite axonal MAP2 staining being very weak at DIC 7 
(Caceres et al., 1986), HCA-Vision software was able to detect it, and thus axons were taken 
into account. Thus, is possible that the maximal neurite length might be the neuronal axon, 
while the number of roots may vary depending on the number of dendrites formed. 
In order to analyse neurons with HCA-Vision software, cells have to be plated at low 
density, with a range of 1-5x104cells/mL, to avoid cell-cell contact (Vallotton et al., 2007). 
Therefore, in this work, cells were plated at 4x104cells/mL. As a result, most of the cells 
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analysed were isolated neurons, with no contacts between them. When two cells overlap 
neurites, results are more subjective, being necessary to decide whether a neurite belongs to 
one or other of the two cells. 
 
Figure 3.3 – Representative images of fluorescence image analysis of two DIC 7 cultured cortical neurons by 
HCA-Vision software. Images with two channels (one for nucleus and other for cell structure) taken with an 
inverted widefield fluorescence microscope (Zeiss Axiovert 200, Germany), with a 40x objective, and using the 
Zeiss filter sets 49 and 15 for detection of DAPI and Alexa Fluor 568 antibody conjugated, respectively, were 
analyzed by HCA-Vision software. A three-step analysis was performed in order to obtain a virtual image of 
these two neurons: neuron body detection (A), neurite detection (B), and neurite analysis, where detected 
neurites in B are associated to neuron bodies already detected in A, forming thus two virtual neuronal images 
(C). 
Figure 3.4 – Schematic representation of a neuron 
analysed by HCA-Vision software. With HCA-Vision 
software analysis it is possible to obtain a virtual image 
of a neuron from which can be measured the 
morphological parameters: total neurite length, that 
are sum of the length of each neurite segment (S1 to 
S7); maximal neurite length, which corresponds to the 
the length of the longest path from a neuron body to an 
extreme segment (S6 + S7); number of branch points, 
the number of points where a neurite structure splits 
into two or more branches (B1 to B3); and number of 
roots, which are the the number of points where neurite structure touches a neuron body (R1 to R2). (image 
obtained from Bio Image Analysis Workshop (2008), CSIRO Biotech Imaging)  
A B C
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Figure 3.5 – Virtual images of two neurons obtained by HCA-Vision software. With a virtual image (A), it is 
possible for the software to measure the morphological parameters: total neurite lengh (B), maximal neurite 
length (C), number of branch points (D) and number of roots (E). From these two virtual neuronal images, 
total neurite length is 374.86 and 339.55 μm for the green and pink neurons (B), respectively. In the case of 
maximal neurite length, green and pink neurons have respectively 62.49 and 69.68 μm (C). The number of 
branch points measured for green and pink neurons were 18 and 14 (D), and the number of roots 5 and 8 (E), 
respectively. 
3.4 Electrophoresis and Immunoblotting 
DIC 1, 3, 5 and 7 were lysated by adding to the 85-mm plate 250μL of 0.32M sucrose 
solution with 50mM Tris at pH 7.6, plus protease inhibitors (ROCHE) and scraping the plate 
with the help of a cell scraper. It was centrifuged at 1000g during 10 minutes at 4°C. The 
supernatant, corresponding to the dissociated cells, was collected. Protein was quantified 
according to Bradford assay (1976) using the Bio-Rad Protein assay kit. This sample was used 
for relative quantification of the proteins presented in Table 3.1. 
Lysates were denaturated with 5x sample buffer (350mM Tris, 30% glycerol, 10% SDS, 
600mM dithiothreitol, and 0.012% bromophenol blue, pH 6.8). 10% polyacrilamide gel 
samples were boiled at 100˚C and 12% polyacrilamide gel were heated at 80˚C, both with 
open cap, in order to concentrate samples and reach a 20μL and 150μL volume, respectively, 
before loading in the polyacrilamide gel. 10% polyacrilamide gel was performed with 10-wells, 
A B C
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while 12% with 5-well, to allow a higher amount of protein, namely A2A receptor, as it is very 
difficult to detect in cortical neurons due to its low protein expression levels. Proteins were 
run in SDS-polyacrylamide gels, which were mounted in the electrophoresis apparatus filled 
with running buffer (25mM Tris, 192 glycine, 0.1% SDS). Equal volumes of samples were 
loaded into gels (Table 3.1). Samples were stacked by running at 80 V and resolved at 140 V. 
Proteins in the polyacrylamide gel were transferred to polyvinylidene fluoride (PVDF) 
membranes, previously wet in methanol, during 1h 40min at room temperature in transfer 
buffer (24mM Tris, 182 mM glycine, 15% methanol). PVDF membranes are particularly 
effective for use with the chemiluminescent detection system that was employed, and 
because it has high affinity for proteins, it will allow some strippings of the membrane, so that 
it was possible to detect more than one protein in the same membrane. After the proteins had 
been transferred to the PVDF membrane, a blocking step was performed with 5% nonfat 
powdered milk dissolved in TBS (Tris Buffered Saline) (0.2mM Tris, 137 mM NaCl) with 0.1% 
Tween-20 (TBS-T) for 1h at room temperature, to saturate all the sites of the membrane not 
already bound with protein. After the proteins have been transferred to the PVDF membrane 
and the unoccupied sites have been blocked with milk protein, the incubations with the 
primary antibodies (presented in Table 3.1) against the protein of interest were performed 
overnight at 4°C, all of them diluted in 3% BSA in TBS-T and 0.02% sodium azide (NaN3), which 
functions as a bacteriocide. During the incubation, the antibody binds to the protein of 
interest; however it can also bind nonspecifically to other proteins on the membrane. 
Nonspecific binding of the antibody is decreased or prevented by the disruption of these 
interactions by the presence of TBS containing a non-ionic (nondenaturating) detergent, 
polyoxyethylenesorbitan monolaurate (Tween 20) (4 x 10 min). The membrane was then 
incubated for 1h, at room temperature, with the secondary antibody directed to the species-
specific IgG portion of the primary antibody, diluted in the blocking buffer. This secondary 
antibody was conjugated with the enzyme horseradish peroxidase (HRP), the critical 
component necessary for the luminescent chemical reaction. Any secondary antibody that had 
bound nonspecifically to proteins on the membrane other than the IgG of the primary 
antibody to be detected, was removed by washing again the PVDF membrane with TBS 
containg Tween 20 (4 x 10 min). After washing the PVDF membrane with a buffer containing 
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Tween 20, detection of proteins was made with ECL plus Western blotting detection reagent 
(GE Healthcare). This system is based on the combined reaction of HRP and peroxide catalyzed 
oxidation of the Lumigen PS-3 Acridan substrate, generating acridinium ester intermediates, 
which reacting with peroxide under slight alkaline conditions produce a sustained, high 
intensity chemiluminescence with maximum emission at a wavelength of 430nm. The 
resulting light is detected on a X-Ray film (Fujifilm). Band intensities were quantified using the 
Image J software (NIH). 
Table 3.1 – Primary and secondary antibodies and related conditions used in the Western blot experiments 
for individual proteins. All primary antibodies were diluted in 3% Bovine Serum Albumin with 0.02% NaN3 and 
secondary antibodies in 5% non-fat dry milk. 
Protein 
Protein 
loading 
(μg) 
Resolving 
gel % 
Primary 
antibody 
Animal Dilution 
Secondary 
antibody 
Dilution 
A2AR 125 12 
Upstate 
(05-717) 
Mouse 1:3000 
Santa Cruz 
Biotechnology 
Goat 
anti-mouse 
( sc-2005) 
Goat 
anti-rabbit  
(sc-2004) 
1:2500 
TrkB 20 10 
BD Biosciences 
(610101) 
Rabbit 1:1000 1:7500 
MAP2 125 12 
Millipore 
(MAB3418) 
Mouse 1:1000 1:10000 
-Tubulin 125 12 
Abcam 
(ab4074) 
Rabbit 1:2000 1:15000 
Tau 125 12 
Synaptic Systems 
(314 002) 
Rabbit 1:3000 1:15000 
-Actin 20/125 10/12 
Abcam 
(ab8227) 
Rabbit 1:10000 1:20000 
GAPDH 20/125 10/12 
Ambion 
(AM4300) 
Mouse 1:4000 1:20000 
Abbreviations: A2AR – Adenosine A2A Receptor; TrkB – Tropomyosine related kinase B; MAP2 – Microtubule-
associated protein 2; GAPDH – Glyceraldehyde-3-phosphate dehydrogenase 
The removal of primary and secondary antibodies (stripping) from membrane, to 
reprobe over again with an antibody against a different protein, was possible by using a 
sequence of acetic acid solutions with increasingly lower pH 2.8-2.5 (glycine 0.2M; NaCl 0.5M 
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and 0.4M, respectively; and acetic acid to adjust the pH). After washing the membranes, they 
were blocked again to detect different proteins using the procedure described above. 
3.5 Drugs 
BDNF was a kind gift of Regeneron Pharmaceuticals, USA. 4-[2-[[6-Amino-9-(N-ethyl-b-
D-ribofuranuronamidosyl)-9H-purin-2-yl]amino]ethyl]-benzene propanoic acid hydrochloride 
(CGS21680), a selective agonist of A2A receptor;  4-(2-[7-Amino-2-(2-furyl)[1,2,4]triazolo[2,3-
a][1,3,5]triazin-5-ylamino]ethyl)phenol (ZM241385), a potent and highly selective A2A 
adenosine receptor antagonist; and  1-[6-[[(17b)-3-Methoxyestra-1,3,5(10)-trien-17-
yl]amino]hexyl]-1H-pyrrole-2,5-dione (U73122), a phospholipase C inhibitor, were obtained 
from Tocris Bioscience (Bristol, UK). Adenosine deaminase (ADA, from calf intestine 
10mg/2mL, EC 3.5.4.4) was from Roche (Germany). 2-(4-Morpholinyl)-8-phenyl-1(4H)-
benzopyran-4-one (LY294002), a highly selective inhibitor of phosphatidylinositol 3-kinase (PI-
3 kinase); and 1,4-Diamino-2,3-dicyano-1,4-bis(2-aminophenylthio)butadiene (U0126), a 
selective Mkk (MAP kinase kinase) inhibitor, were obtained from Ascent Scientific (Bristol, UK). 
Rp-Adenosine 3’,5’-cyclic monophosphorothioate triethylammonium salt hydrate, and Rp-
Cyclic 3’,5’-hydrogen phosphorothioate adenosine triethylammonium salt (Rp-cAMPS), a 
blocker of cAMP-mediated effects. 
3.6 Statistics 
All data are expressed as mean ± SEM from the indicated number of independent 
cultures. Statistical significance was determined with the help of GraphPad software, using 
one-way analysis of variance (ANOVA) followed by Bonferroni correction for multiple 
comparisons. When only two means were compared, the Student’s t-test was used. Values of 
p < 0.05 were considered to represent statistically significant differences. 
In each different experiment referring to morphometric measurements, statistical 
significance of differences from the different grouped conditions was determined as described 
above, which corresponds to the number of independent cultures. Each experimental grouped 
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condition corresponds to 50 measurements taken from 50 individual cells. Thus, first analysis 
is performed inside each group of 50 measurements per condition per experiment, and then 
grouped data per condition from all experiments was statistically analysed. 
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4 RESULTS 
During neuronal differentiation/maturation, neurons undergo a series of “violent” 
morphological modifications. These changes involve the formation of a series of processes in 
which, at a certain time, one of these processes differentiates into an axon and the rest into 
dendrites, with later ramification. These morphological characteristics are modulated by 
external signalling cues, by activating receptors expressed on the surface of neuronal 
membranes, which promote or inhibit the increase or decrease in the number of formed 
processes, as well as its length and ramification. Consequently, the activation of these 
membrane receptors with selective agonists, or its inhibition by the correspondent 
antagonists, coupled to the measurement of the different neuronal morphological properties, 
described above, constitute a very important tool to study neuronal maturation. 
For the reasons presented in the Introduction, I focused my work on BDNF TrkB and 
adenosine A2A membrane receptors. By activating and/or inhibiting these receptors, I 
measured the induced neuronal morphological effects to understand their role on neuronal 
outgrowth. 
4.1 Expression levels of Adenosine A2A and BDNF TrkB Receptors during 
Neuronal Differentiation in Cortical Cultures 
Before studying the roles of TrkB and A2A receptor during neuronal maturation it is very 
important to see if these proteins are present. For that, through western blot analysis, I 
measured the expression levels of A2A receptor and TrkB during the time cortical neurons 
were in cultured, such as at DIC 1, 3, 5 and 7, in control conditions. The internal control used, 
in order to eliminate the error associated to the experiment process for each condition, was 
glyceraldehyde-3-phosphate dehydrogenase (GAPDH). GAPDH protein is a cytosolic enzyme 
(EC 1.2.1.12) which is involved in the cellular metabolism, namely in glycolysis, the breakdown 
of glucose, and also in other great number of cellular processes. GAPDH is constitutively 
expressed in almost all tissues at high levels and at relatively constant rate. For that reason 
this protein is highly used as a loading control, including during development of cultured 
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neurons (for example Czesak et al., 2007). On the other hand, -actin is a protein that makes 
part of the cytoskeleton, mainly in the structure of filopodia and lamellipodia. Normally it is 
also used as an internal control in mature neurons, as its expression does not change, 
remaining relatively constant (Sturzenbaum and Kille, 2001). However, its expression levels 
may alter during neuronal differentiation (Sturzenbaum and Kille, 2001; Ruan and Lai, 2007), 
what can compromise its use as an internal control. 
Although GAPDH protein, for the reasons mentioned above, should be used as an 
internal control, for practical reasons it was not possible to do that, since in some replicates 
GAPDH protein run out from the gel. Whenever possible I normalized -actin to GAPDH and I 
found out that -actin levels do not change, relatively to GAPDH, during the time cortical 
neurons were in culture (Figure 4.1). As a result, I used -actin as an internal control for the 
measure of the expression levels of A2A and TrkB receptors. 
 
Figure 4.1 – -Actin levels in cortical neurons throughout 7 days in culture. DIC 1, 3, 5 and 7 cortical neurons 
were lysated with 0.32M sucrose solution with 50mM Tris (pH 7.6), as described in Methods. 
Immunoreactivity of -actin protein was measured for all the different days in culture. Specific 
immunoreactivity was normalized to that of GAPDH. Results are expressed as mean ± SEM of four 
independent cultures. On the right a representative image of the western blot is presented. 
As we can observe from the Figure 4.2 A and B, TrkB expression levels in cortical 
neurons increase during the time in culture (Figure 4.2 B), and A2A receptor seems to be quite 
constant or may seem to increase with a peak at DIC 5, although with a high degree of 
instability from culture to culture (Figure 4.2 A). A positive control using striatum tissue was 
always used to confirm that the observed band corresponded to specific A2A receptors 
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immunoreactivity. It was already shown in cortical neurons, by Aden et al. (2000), that, at 
embryonic day 18 (E18), A2A receptor protein is almost undetectable, increasing until 
postnatal day 14 (P14) (Adén et al., 2000). In the case of TrkB, it was shown in the neocortex 
that the mRNA of full-length TrkB reach their adult levels by birth, while truncated TrkB does 
not peak until P10-15. (Fryer et al., 1996), which can have a relationship with the protein 
expression. Hence, during the time cultured cortical neurons are treated with A2A receptor 
agonist and BDNF endogenous ligand, those correspondent receptors are already expressed. 
 
Figure 4.2 – Adenosine A2A and TrkB receptors levels in cortical neurons throughout 7 days in culture. DIC 1, 3, 
5 and 7 cortical neurons were lysated with 0.32M sucrose solution with 50mM Tris (pH 7.6), as described in 
Methods. Immunoreactivity of A2A (A) and TrkB (B) receptor proteins both measured for all the different days 
in culture. Specific immunoreactivity was normalized to that of -actin. Results are expressed as mean ± SEM 
of six independent cultures. On the top representative images of the western blot is presented. 
Other protein levels, in control conditions, were also measured in order to see the 
variation in their expression during the seven days cortical neurons are in culture. Examples of 
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these proteins are cytoskeletal proteins such as -tubulin, MAP2 and tau (Figure 4.3 A, B and 
C, respectively). 
 
Figure 4.3 – MAP2, α-tubulin and tau protein levels in cortical neurons throughout 7 days in culture. DIC 1, 3, 
5 and 7 cortical neurons were lysated with 0.32M sucrose solution with 50mM Tris (pH 7.6), as described in 
Methods. Immunoreactivity of MAP2 (A), -tubulin (B) and tau (C) proteins were measured for all the 
different days in culture. Specific immunoreactivity was normalized to that of -actin. Results are expressed as 
mean ± SEM of seven (for MAP2 and tubulin) and five (for tau) independent cultures. On the top 
representative images of the western blot is presented. 
MAP2, microtubule associated protein 2, is a protein that interacts with both 
microtubules (Kim et al., 1979) and actin filaments (Selden and Pollard, 1983; Sattilaro, 1986; 
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Selden and Pollard, 1986). MAP2 is an abundant protein expressed during all stages of 
neuromorphogenesis (Caceres et al., 1986). First, it is expressed in neuroblasts before neurite 
initiation, then it is present in minor processes, one of which will differentiate into an axon. At 
later stages, DIC 7, MAP2 has almost disappeared from axons but is retained in dendrites 
(Caceres et al., 1986). During the seven days cortical neurons were in culture, MAP2 protein 
levels significantly increased throughout the time (Figure 4.3 A). 
In the case of -tubulin, this protein belongs to the tubulin family, and together with 
-tubulin, these proteins form dimmers which are responsible for making up microtubules. 
Expression levels measurement showed that -tubulin also increases in its protein levels 
during the seven days in culture (Figure 4.3 B). The same variation profile is observed for tau 
protein (Figure 4.3 C). Tau is a microtubule-associated protein that interacts with tubulin to 
stabilize microtubules and promote tubulin assembly into microtubules. 
4.2 Function of BDNF TrkB and Adenosine A2A Receptors in Neuronal 
Maturation 
As adenosine, through A2A receptor activation, modulates BDNF actions on several 
neuronal functions, such as in synaptic transmission and plasticity, it was hypothesized that 
adenosine, through A2A receptor activation, was able to modulate BDNF actions upon 
neuronal maturation. In order to explore this hypothesis, I first had to define the actions of 
each of these modulators in these experimental conditions. Then I evaluated the crosstalk 
between both A2A and TrkB receptors. 
Dissociated cortical cultures were treated, at DIC 3, with the selective A2A receptor 
agonist CGS 21680 (10nM) and/or the antagonist ZM 241385 (50nM) 20 minutes before BDNF 
(20ng/mL). All these ligands remained in the medium until fixation at DIC 7. Through 
immunocytochemistry, MAP2 and DAPI were stained with fluorescent labels (Figure 4.4) to 
allow morphometric measurements through the use of HCA-Vision software. Morphological 
parameters, considered relevant for quantitative analysis, were 1) the total neurite length, 2) 
the maximal neurite length, 3) the number of branch points and 4) the number of roots. 
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Figure 4.4 Representative images of cortical neurons with 7 days in culture, showing morphological 
differences in the number of roots, maximal neurite length and number of branch points. E18 rat primary 
cultures of cortical neurons were treated with the A2A receptor agonist CGS21680 (10nM) and/or the 
antagonist ZM241385 (50nM) 20 minutes before the TrkB endogenous ligand BDNF (20ng/mL), from DIC 3 to 
DIC 7. At DIC 7, cultures were fixed and immunostained for microtubule-associated protein 2, MAP2 (red), and 
with the DAPI nuclear stain (blue). Images were taken with an inverted widefield fluorescence microscope 
(Zeiss Axiovert 200, Germany), with a 40x objective. 
In a control condition, the average length of the total neurites was 333.4 ± 11.61 μm. 
When the endogenous ligand of TrkB receptor, BDNF (20ng/mL), or the selective agonist of 
adenosine A2A receptor, CGS 21680 (10nM), when applied to the cultures, there was an 
increase of the total neurite length for 46 ± 5.1 % (n=3, p<0.05) and 21 ± 4.4 % (n=3, p<0.05), 
respectively (Figure 4.5). Moreover, when both ligands were present together, CGS 21680 and 
BDNF, there was an increase in about 59 ± 5.1 % (n=3, p<0.05) of the total neurite length 
compared to the control condition.  
 
Figure 4.5 Influence of A2A receptors and BDNF upon Total Neurite Length of cultured cortical neurons. 
Neurons from four cultures were analysed by HCA-Vision software in terms of maximal neurite length at DIC 
7, after four days in long term treatment with the A2A receptor agonist CGS 21680 (10nM) and/or the A2A 
receptor antagonist ZM241385 (50nM) 20 minutes before BDNF (20ng/mL). Neurons from three cultures were 
analysed by HCA-Vision software. For each culture, fifty neurons were counted from each condition. Error 
bars represent SEM from independent cultures. *** p < 0.0001, compared with control, unless otherwise 
indicated; § p < 0.0001, compared with CGS 21680 (10nM) + BDNF (20ng/mL) (One-way ANOVA, Bonferroni's 
Multiple Comparison Test). 
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The presence of the antagonist of adenosine A2A receptor, ZM 241385 (50nM), 
prevented the effect of CGS 21680 (n=3, p>0.05) as it was expected, however it did not affect 
BDNF action (Figure 4.5). Indeed, in the presence of ZM 241385, BDNF increased total neurite 
length for 46 ± 5.1 % (n=3, p<0.05), a value very similar (p>0.05) to that observed when the 
TrkB ligand was added to neurons in the absence of the A2A receptor antagonist. The addition 
of BDNF, to neurons in the presence of CGS 21680 and ZM 241385, increased by 47 ± 4.9 % 
(n=3, p<0.05) the total neurite length, a value also similar (p>0.05) to that observed in the 
presence of BDNF alone.  
Altogether this data suggest that A2A receptors do not influence the action of TrkB 
receptors upon the total neurite length. Total neurite length is just a measure of the length of 
total neurites that exist, i.e. total neurite length, apart from being dependent on the length of 
each neurite, it is also dependent on the number of neurites, and the branching of each 
neurite. Consequently, this morphological measurement is a sum of different morphological 
characteristics, in which some can be modulated by one ligand and others by the other, or 
even in some there could be an interaction between both ligands. This, I cannot see from just 
this morphological measurement. I can just confirm that BDNF and A2A receptor activation 
have a role in neuronal maturation. 
4.2.1 Specific role of Adenosine A 2 A Receptor activation in Neuronal 
Maturation 
To unveil the function of A2A receptors, I then quantified the influence of A2A receptor 
ligands on the number of roots, maximal neurite length and number of branch points (Figure 
4.6). The A2A receptor agonist CGS 21680 (10nM) did not have any influence neither on the 
number of branch points (n=3, p>0.05) nor in the number of roots (n=3, p>0.05) (Figure 4.6). 
However, it increased the maximal neurite length for about 30 ± 5.0 % (n=3, p<0.05), an action 
that was completely prevented by the presence of ZM 241385 (50nM), the antagonist of A2A 
receptor (n=3, p>0.05), which demonstrates that the effect of CGS 21680 is due to A2A 
receptors activation. 
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Figure 4.6 Activation of adenosine A2A receptor with 
the selective agonist CGS 21680 (10nM) increases 
maximal neurite length (A), and has no effect in the 
number of branch points (B) and in the number of 
roots (C). The antagonist of A2A receptor, ZM241385, 
prevents CGS21680 action in increasing the length of 
the maximal neurite (A). Neurons from three 
cultures were analysed by HCA-Vision software. For 
each culture, fifty neurons were counted from each 
condition. Error bars represent SEM from independent cultures. * p < 0.05*** p < 0.0001, compared with 
control, unless otherwise indicated (One-way ANOVA, Bonferroni's Multiple Comparison Test).  
4.2.2 Specific role of BDNF action in Neuronal Maturation 
As already reported, by Dijkhuizen and Ghosh, BDNF is involved in the regulation of 
primary dendrites (Dijkhuizen and Ghosh, 2005) and in the branching of cortical neurons 
(Niblock et al., 2000). Thus, to make sure of the role of BDNF in neuronal differentiation under 
my experimental conditions, I explored BDNF effects by measuring the same morphological 
parameters which were used to analyse A2A receptor actions in neuronal differentiation, such 
as the number of roots and number of branch points, and the maximal neurite length. 
In contrast to A2A receptor activation effects in neuronal maturation, BDNF did not 
affect the length of the maximal neurite (n=6, p>0.05; Figure 4.7 A), but it did induce the 
increase in the number of branch points (Figure 4.7 B) and in the number of roots (Figure 4.7 
C), by 61 ± 5.1 % (n=6, p<0.05) and 50 ± 2.6 % (n=6, p<0.05), respectively. 
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Figure 4.7 BDNF increases number of branch points (B) and number of roots (C) of cultured cortical neurons, 
and has no effect in maximal neurite length (A). Neurons from six independent cultures were analysed by 
HCA-Vision software. For each culture, fifty neurons were counted from each condition. Error bars represent 
SEM from independent cultures. *** p < 0.0001, compared with control (One-way ANOVA, Bonferroni's 
Multiple Comparison Test). 
4.2.3 Modulatory action of Adenosine A 2 A Receptor upon BDNF effects in 
Neuronal Maturation 
To further explore the hypothesis of A2A receptor activation could be modulating 
BDNF actions, the effect of BDNF on the number of branch points and number of roots was 
tested in the presence of the A2A receptor antagonist, ZM 241385 (50nM), or the A2A receptor 
agonist, CGS 21680 (10nM). Maximal neurite length was also analysed under these conditions. 
As it was already described in section 4.2.2, BDNF (20ng/mL) did not influence 
maximal neurite length, however ZM 241385 (50nM) slightly decreased the maximal neurite 
length, for 10 ± 2.8 % (n=6, p<0.05) (Figure 4.8 A). This can be due to blockade of the 
endogenous activation of A2A receptor by the presence of endogenous adenosine in the 
culture medium. Somehow unexpectedly, BDNF added to neurons in the presence of ZM 
241385 causes a further inhibition (8 ± 3.0 %, n=6, p<0.05) of maximal neurite length (Figure 
4.8 A). Regarding the number of roots, which is affected by BDNF alone, this action is not 
influenced by blockade of A2A receptors with ZM 241385 (n=6, p>0.05) (Figure 4.8 C). Indeed, 
the increase induced by BDNF, in the presence of the A2A receptor antagonist (42 ± 2.3 %, n=6, 
p<0.05), was similar (p>0.05) to the one observed in the absence of the antagonist (50 ± 2.6 %, 
n=6, p<0.05) (Figure 4.8 C). In the case of the number of branch points, there is a difference 
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(p<0.05) between the effect induced by BDNF in the absence of ZM 241385 with the one in 
the presence. However, as ZM 241385 decreased the branching compared to the control 
condition, the attenuation apparently observed may not be real, as BDNF induced the same 
percentage of increase in the presence of A2A receptor antagonist (56 ± 5.3 %, n=6, p<0.05) 
and in the absence of the antagonist (61 ± 5.1 %, n=6, p<0.05). 
 
Figure 4.8 Influence of A2A receptor blockade upon 
the effect of BDNF. The A2A receptor antagonist, ZM 
241385, attenuated BDNF action upon number of 
branch points (B), but not in the number of roots (C), 
and unmasked an inhibitory effect in maximal neurite 
length by BDNF (A). Neurons from six independent 
cultures were analysed by HCA-Vision software. For 
each culture, fifty neurons were counted from each 
condition. Error bars represent SEM from 
independent cultures. * p < 0.05, ** p < 0.001, *** p < 0.0001, compared with control, unless otherwise 
indicated (One-way ANOVA, Bonferroni's Multiple Comparison Test). 
The experiments described up to now show that receptor blockade does not influence 
BDNF actions in neuronal maturation, suggesting that endogenous activation of A2A receptor 
does not modulate the TrkB actions. These results do not exclude the possibility that 
overactivation of A2A receptors could modulate BDNF actions. So, next I tested the influence of 
the presence of the A2A receptor agonist in the actions of BDNF, namely in the number of 
roots (Figure 4.9 A) and number of branch points (Figure 4.9 B). 
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Figure 4.9 Number of Roots of cultured cortical neurons. Neurons from four independent cultures were 
analysed by HCA-Vision software in terms of maximal neurite length at DIC 7, after four days in long term 
treatment with the A2A receptor agonist CGS 21680 (10nM) and/or the antagonist ZM 241385 (50nM) 20 
minutes before BDNF (20ng/mL). Neurons from three cultures were analysed by HCA-Vision software. For 
each culture, fifty neurons were counted from each condition. Error bars represent SEM from independent 
cultures. ** p < 0.001, *** p < 0.0001, compared with control, unless otherwise indicated; § p < 0.0001, 
compared with ZM 241385 (50nM) (One-way ANOVA, Bonferroni's Multiple Comparison Test). 
The presence of CGS 21680 (10nM) did not alter the influence of BDNF (20ng/mL) upon 
the number of roots (n=3, p>0.05). Thus, in the presence of CGS 21680, BDNF increased the 
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number of roots by 67 ± 4.0 % (n=3, p<0.05) and, in the absence of CGS 21680, increased by 
63 ± 3.9 % (n=3, p<0.05) (Figure 4.9 A), both effects being not significantly (p>0.05) different. 
In the case of the number of branch points (Figure 4.9 B) there was an increase in the 
number of branch points induced by BDNF in the presence of CGS 21680 (10nM) by 71 ± 8.6 
(n=3, p<0.05), a value greater than the one observed in the absence of A2AR agonist, 47 ± 7.3 
% (n=3, p<0.05). Thus, the data suggests that A2A receptor activation may modulate BDNF 
actions upon neuronal branching. 
4.3 Concentration dependency of the effects of the A2A Receptors 
agonist 
Since 10nM of CGS 21680 did not have any effect in the number of branch points, but 
previous preliminary results performed in the lab pointed towards an effect, I decided to 
evaluate the change in the number of branch points as a function of the concentration of the 
A2A receptor agonist CGS 21680. For that I tested different concentrations of CGS 21680, 
namely 10nM, 30nM and 100nM; the abcense of CGS 21680 was tested as the control 
condition. The KD value for CGS 21680 towards A2A receptors is 15.5 ± 2 nM (Jarvis et al., 
1989), and the concentrations used, 10, 30 and 100nM, were respectively about 0.5 times 
lower and 2 - 6.5 times higher than the KD. Hence, the KD value may explain the absence of 
effect in the number of branch points by CGS 21680 10nM. 
These different concentrations were applied to cultures medium at DIC 3 and 
remained present until fixation at DIC 7. Using HCA-Vision software, morphological properties, 
such as total neurite length, maximal neurite length, number of branch points and number of 
roots, were measured. It was observed (Figure 4.10) an increase in total and maximal neurite 
length, as well as in the number of branch points, in a concentration dependent-manner, with 
a maximal effect of CGS 21680 at 30nM. In contrast, CGS 21680 did not have any effect in the 
number of roots, at any concentration used. The concentration of 100nM of CGS 21680 ([CGS 
21680]>>KD(A2A receptor)) caused a smaller (p<0.05) effect than that of 30nM (Figure 4.10 A, B 
and C). A short term exposure to a higher concentration of agonist can induce the occurrence 
of a desentitization process, in which the higher concentration of CGS 21680 compared to A2A 
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receptor agonist KD, leads to an uncouplement of the A2A receptor and the G-protein to which 
the receptor is coupled.On the other hand, long term exposure of A2A receptor to its agonist 
CGS 21680 was observed to induce a downregulation, i.e. a decrease in the expression levels, 
of this receptors (Klaasse et al., 2008). Thus, a high concentration of A2A receptor agonist can 
possibly induce a stronger downregulation of A2A receptors, promoting a decrease of the 
effect induced by this receptor, as it may be happening with CGS 21680 100nM. In the 
following experiments, I used only the concentration of CGS 21680 that caused maximal 
effects, which was 30nM. This concentration had already been tested in terms of cell viability 
in the host lab, not affecting it (data not shown). 
 
Figure 4.10 The A2A receptors agonist, CGS 21680 increases total neurite length (A), maximal neurite length (B) 
and number of branch points (C) in neuronal cortical cultures in a concentration-dependent manner. Maximal 
effect of CGS 21680 is observed at 30nM. CGS 21680 does not change the number of roots (D). Neurons from 
four independent cultures were analysed by HCA-Vision software. For each culture, fifty neurons were 
counted from each condition (without and with CGS 21680 10/30/100nM). Error bars represent SEM from 
independent cultures. * p < 0.05, ** p < 0.001, *** p < 0.0001, compared with control, unless otherwise 
indicated (One-way ANOVA, Bonferroni's Multiple Comparison Test).  
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After choosing the CGS 21680 concentration to be used, neuronal cortical cultures 
were treated with CGS 21680 (30nM) in the presence or absence of ZM 241385 (50nM) from 
DIC 3 to DIC 7, in order to confirm if, at this concentration, the effect of CGS 21680 could still 
be attributed to A2A receptor activation. This was confirmed by the total prevention of the 
agonist effects upon maximal neurite length and the number of branch points (Figure 4.11). 
 
Figure 4.11 The effect of 30nM of the A2A receptor agonist, CGS 21680, can still be attributed to A2A receptor 
activation since the antagonist, ZM 241385, prevents CGS 21680 actions upon maximal neurite length (A) and 
the number of branch points (B). Neurons from three independent cultures were analysed by HCA-Vision 
software. For each culture, fifty neurons were counted from each condition. Error bars represent SEM from 
independent cultures. * p < 0.05, ** p < 0.001, *** p < 0.0001, compared with control, unless otherwise 
indicated (One-way ANOVA, Bonferroni's Multiple Comparison Test).  
4.4 Endogenous influence of Adenosine in Neuronal Maturation 
Adenosine, which is released by neurons and glial cells, may accumulate in the 
extracellular medium of neurons in culture. Therefore, I investigated if endogenous 
adenosine, by the tonic activation of A2A receptors, could influence the actions of BDNF, or 
even have some neuronal effect by itself (e.g. increasing maximal neurite length). To look for 
the importance of endogenous adenosine in neuronal maturation, adenosine deaminase 
(ADA), an enzyme that metabolizes adenosine to inosine (Meijer et al., 2008) and does not 
penetrate in cell membranes, was added to the culture medium so that it could remove the 
presence of external adenosine.  
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4.4.1 Endogenous influence of Adenosine upon A 2 A Receptor activation 
First, I explored the action of endogenous adenosine in the activation of A2A receptor, 
adding to the medium ADA (1U/mL), at DIC 3, 1h before the addition of CGS 21680 (30nM). 
Drugs remained in the medium until fixation at DIC 7. Measurements of the morphological 
properties showed (Figure 4.12 and 4.13) that the elimination of endogenous adenosine from 
the medium by ADA, did not affect (n=3, p>0.05) the enhancement caused by CGS 21680, in 
the maximal neurite length and number of branch points (percentage of increase: 36 ± 5.5 % 
and 16 ± 5.6 %, respectively, in the absence of ADA, and respectively 35 ± 5.6 % and 19 ± 4.8 
%, in the presence of ADA). In addition, and more important, when ADA was present there 
was no change in any morphological property (n=3, p>0.05) compared to control conditions 
(Figure 4.12 and 4.13). As previously observed (Figure 4.8 A), ZM 241385 induced a decrease 
in maximal neurite length. Thus, it seems that A2A receptors are tonically activated by 
endogenous adenosine, although this activation is just sufficient to induce elongation of the 
maximal neurite. The reason for ADA not affecting maximal neurite length as ZM 241385 did, 
can be explained by the presence of other adenosine receptors with actions opposite to those 
of A2A receptors, so that upon removal of endogenous adenosine both effects remain 
balanced. 
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Figure 4.12 Representative images of cortical neurons with 7 days in culture, showing morphological 
differences in the maximal neurite length, number of roots and branch points. E18 rat primary cultures of 
cortical neurons were treated with adenosine deaminase (ADA) 1h before the A2A receptor agonist CGS21680 
(10nM) or the TrkB endogenous ligand BDNF (20ng/mL), from DIC 3 to DIC 7. At DIC 7, cultures were fixed and 
immunostained for microtubule-associated protein 2, MAP2 (red), and with the DAPI nuclear stain (blue). 
Images were taken with an inverted widefield fluorescence microscope (Zeiss Axiovert 200, Germany), with a 
40x objective. 
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Figure 4.13 ADA (1U/mL) does not influence A2A receptor agonist CGS 21680 (30nM) actions upon maximal 
neurite length (A), number of branch points (B) and number of roots (C). Neurons from three cultures were 
analysed by HCA-Vision software. For each culture, fifty neurons were counted from each condition. Error 
bars represent SEM from independent cultures. * p < 0.05, ** p < 0.001, *** p < 0.0001, compared with 
control, unless otherwise indicated (One-way ANOVA, Bonferroni's Multiple Comparison Test).  
4.4.2 Endogenous influence of Adenosine upon BDNF actions  
After looking for the action of endogenous adenosine in the activation of A2A receptor, 
we looked for any influence of this endogenous purin nucleoside upon BDNF actions. For that, 
at DIC 3, ADA was added to the medium 1h before the addition of BDNF, remaining present in 
the medium until DIC 7, when cultures were fixed. The morphometric quantifications (Figure 
4.14) showed an attenuation (n=3, p<0.05) of the ability of BDNF to increase the number of 
branch points and the number of roots (percentage of increase: 40 ±6.2 % and 21 ±2.8 %, 
respectively, induced by BDNF in the presence of ADA, compared to respectively 76 ± 6.8 % 
and 37 ± 3.0 % in the absence of ADA). 
20
30
40
50
60
70
80
90
100
110
CGS 21680 (30nM)
ADA (1U/mL)
+-
- -
-
+ +
+
***
***
(n=3)
M
ax
 N
e
u
ri
te
 L
e
n
gt
h
 ( 
m
)
10
15
20
25
30
35
40
CGS 21680 (30nM)
ADA (1U/mL)
+-
- -
-
+ +
+
**
(n=3)
N
u
m
b
e
r 
o
f 
B
ra
n
ch
 P
o
in
ts ***
*
A B
Results 
 
 
51 
 
Figure 4.14 ADA (1U/mL) attenuates BDNF (20ng/mL) action upon both number of branch points (A) and 
number of roots (B). Neurons from three independent cultures were analysed by HCA-Vision software. For 
each culture, fifty neurons were counted from each condition. Error bars represent SEM from independent 
cultures. *** p < 0.0001, compared with control, unless otherwise indicated (One-way ANOVA, Bonferroni's 
Multiple Comparison Test). 
4.5 Signalling Pathways 
Since A2A receptors are in most cases positively coupled to adenylate cyclase (Sebastião 
and Ribeiro, 1996; Svenningsson et al., 1999), I hypothesized that this transducing pathway 
could be involved in the previously reported actions of A2A receptors upon neuronal 
maturation. The influence of other transducing pathways, namely those coupled to TrkB 
signalling, MAPK, PI3K and PLC, were also investigated. To do this, dissociated cortical 
cultures were treated with CGS 21680 for 5h, while the different signalling pathways were 
blocked using specific pharmacological inhibitors. Activation of the MAPK, PI3K, and PLC 
pathways was blocked using U0126 (10γM), LY294002 (50μM), and U73122 (5μM), 
respectively (Dijkhuizen and Ghosh, 2005). In the case of the PKA pathway, its activation was 
blocked by Rp-cAMPS (100μM), an inactive analogue of cAMP that inhibits activation of PKA 
by substrate competition (Lochner and Moolman, 2006; Assaife-Lopes et al., 2010). Because 
PI3K pathway has been shown to play an essential role in neuronal survival, any loss of 
function of this pathway may also affect the survival of the neurons. Indeed, inhibition of PI3K 
during an early stage of dendritic formation (3-6 DIC) causes profound cell death (Kumar et al., 
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2005). However, ss it was already shown by Dijkhuizen and Ghosh, 5-hour treatment of 
control cultures with inhibitors of the MAPK, PI3K and PLC signalling pathways did not change 
the viability of the cultures, however a longer time, until DIC 7, induce death of cultured 
cortical neurons, as I also confirmed in one culture (data not shown). The concentrations of 
inhibitors used were sufficient to inhibit the transducing pathways, as shown by them by 
Western Blot analysis, using phospho-specific antibodies to account for the inactivation of the 
signalling pathways (Dijkhuizen and Ghosh, 2005). 
4.5.1 Validation of the tools used by evaluating th eir influence upon BDNF 
actions 
Before studying the signalling pathways involved in the action of A2A receptor activity 
upon neuronal maturation, I confirmed the functionality of my experimental conditions as 
well as the functionality of the inhibitors by testing its influence upon the action of BDNF and 
comparing results with those already reported by Dijkhuizen and Ghosh (2005). Accordingly, I 
performed an experiment similar to the one described before. A summary of the data 
obtained is shown in Figures 4.15 and 4.16, for respectively the number of roots and number 
of branch points. 
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Figure 4.15 Exploring the signalling pathways evolved in the increase of the number of roots induced by BDNF. 
Pharmacological inhibition of the signalling pathways MAPK (A), PI3K (B), PLC (C) and PKA (D) pathways with 
U0126 (10μM), LY294002 (50μM), U73122 (5μM) and Rp-cAMPS (100μM), respectively. Neurons from two 
independent cultures were analysed by HCA-Vision software. For each culture, fifty neurons were counted 
from each condition. Error bars represent SEM from independent cultures. * p < 0.05, ** p < 0.001, *** p < 
0.0001, compared with control, unless otherwise indicated (One-way ANOVA, Bonferroni's Multiple 
Comparison Test). 
As previously described by Dijkhuizen and Ghosh (2005), blocking the MAPK pathway 
with U0126 (10μM) completely abolished BDNF-induced neurite formation in cortical neurons 
(Figure 4.15 A) (Dijkhuizen and Ghosh, 2005). Similar results were obtained when the PI3K 
pathway was blocked with the inhibitor LY294002 (50μM) (Figure 4.15 B) (Dijkhuizen and 
Ghosh, 2005). In contrast, inhibiting the PLC, as well as PKA pathways, by U73122 (5μM) and 
Rp-cAMPS (100μM), attenuated, but did not prevent, BDNF-induced dendrite formation (n=2, 
p<0.05) (Figure 4.15 C and D) (percentage of inhibition: 37 ± 5.2 % and 5 ± 4.4 %, respectively, 
compared to the increase induced by BDNF alone for 59 ± 4.6 %). Although PLC transducing 
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pathways was tested by Dijkhuizen and Ghosh (2005) with similar results, PKA pathway was 
still not tested. 
 
Figure 4.16 Exploring the signalling pathways evolved in the increase of the number of branch points induced 
by BDNF (20ng/mL). Pharmacological inhibition of the signalling pathways MAPK (A), PI3K (B), PLC (C) and 
PKA (D) pathways with U0126 (10μM), LY294002 (50μM), U73122 (5μM) and Rp-cAMPS (100μM), 
respectively. Neurons from two independent cultures were analysed by HCA-Vision software. For each 
culture, fifty neurons were counted from each condition. Error bars represent SEM from independent 
cultures. * p < 0.05, ** p < 0.001, *** p < 0.0001, compared with control, unless otherwise indicated. 
In addition to number of roots, number of branch points was also measured. At DIC 3, 
TrkB receptor activation by BDNF induced a smaller increase in the number of branch points 
(15 ± 5.6 %, n=2, p<0.05) (Figure 4.16) than after four days in treatment (61 ± 5.1 %, n= 6, 
p<0.05) (Figure 4.7 B). Measurements of the number of branch points showed that the 
blocking of MAPK and PI3K pathways with U0126 and LY294002, respectively, completely 
prevented CGS 21680 effect in increasing the number of branch points (n=2, p>0.05) (Figure 
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4.16 A and B, respectively), While blocking PKA pathway with Rp-cAMPS did not show 
statistically significant differences between the effect induced by BDNF in the absence and 
presence of ADA (Figure 4.16 D). In contrast, in PLC pathway (Figure 4.16 C), the presence of 
its inhibitor U73122 increased the effect both in the absence and presence of CGS 21680. 
Thus, BDNF action on branch points was prevented by MAPK and PI3K inhibitors and, in a 
lesser extent, by PKA. 
4.5.2 Signalling Pathways activated by Adenosine A 2A Receptors in 
Neuronal Maturation 
Next I went to see the signalling pathways that could be activated during the neurite 
elongation process induced by A2A receptor activation. For that, a similar experiment was 
performed except that the A2A receptor agonist, CGS 21680(30nM), was used instead of BDNF. 
The blockade of MAPK, PI3-K and PLC pathways with U0126, LY294002 and U73122, 
respectively, almost completely prevented the effect of CGS 21680 on the maximal neurite 
length (n=2, p>0.05) (Figure 4.17 A, B and C). In contrast, the PKA pathway (Figure 4.17 D), 
which is the most commonly activated by A2A receptor in a range of adenosine functions, does 
not appear to be crucially involved since the presence of Rp-cAMPS attenuated, but not 
prevented, the effect induced by CGS 21680 (51 ± 6.2 % and 19 ± 5.1 % respectively in the 
absence and presence of Rp-cAMPS) (Figure 4.17 D). 
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Figure 4.17 Exploring the signalling pathways evolved in the increase of the maximal neurite length induced 
by CGS 21680 (30nM). Pharmacological inhibition of the signalling pathways MAPK (A), PI3K (B), PLC (C) and 
PKA (D) pathways with U0126 (10μM), LY294002 (50μM), U73122 (5μM) and Rp-cAMPS (100μM), 
respectively. Neurons from three independent cultures were analysed by HCA-Vision software. For each 
culture, fifty neurons were counted from each condition. Error bars represent SEM from independent 
cultures. * p < 0.05, ** p < 0.001, *** p < 0.0001, compared with control, unless otherwise indicated (One-way 
ANOVA, Bonferroni's Multiple Comparison Test). 
At DIC 3, A2A receptor activation by CGS 21680 (30nM) induced a similar increase in 
the number of branch points (21 ± 5.8 %, n=2, p<0.05) (Figure 4.18) than after four days in 
treatment (16 ± 5.6 %, n=3, p<0.05) (Figure 4.11 B). Measurements of the number of branch 
points showed that the blocking of MAPK, PI3K and PKA pathways with U0126, LY294002 and 
Rp-cAMPS, respectively, completely prevented CGS 21680 effect in increasing the number of 
branch points (n=2, p>0.05) (Figure 4.18 A, B and D), while blocking PLC pathway (Figure 4.18 
C) with U73122 increased the effect both in the absence and presence of CGS 21680. 
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Figure 4.18 Exploring the signalling pathways evolved in the increase of the number of branch points induced 
by CGS 21680 (30nM). Pharmacological inhibition of the signalling pathways MAPK (A), PI3K (B), PLC (C) and 
PKA (D) pathways with U0126 (10μM), LY294002 (50μM), U73122 (5μM) and Rp-cAMPS (100μM), 
respectively. Neurons from two independent cultures were analysed by HCA-Vision software. For each 
culture, fifty neurons were counted from each condition. Error bars represent SEM from independent 
cultures. * p < 0.05, ** p < 0.01, *** p < 0.0001, compared with control, unless otherwise indicated. 
In summary, the pathways that are mainly involved in the elongation of neurites by 
A2A receptor activation are the MAPK, PI3K and PLC pathways, while PKA is relevant in 
neuronal branching, instead of PLC pathway. 
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5 DISCUSSION 
Neuronal differentiation is a crucial process for neurons to acquire their known 
functional morphology, in which specialized processes, as a single axon and multiple 
dendrites, allow neurons to receive, process and transmit information in an unidirectional 
way. As a neuron undergoes terminal differentiation in the distinct layers of the cortical plate, 
it transforms from a motile cell with a leading and trailing process into one that is nonmotile 
but has multiple processes and branches. This requires generation of multiple membrane 
protrusive structures and coordinated changes in actin and microtubule cytoskeleton in 
response to activity-dependent or extracellular neuronal differentiation cues expressed in the 
developing cortical plate. An example of an extracellular cue that is able to induce cytoskeletal 
reorganization, and consequently, induce morphological changes in neurons, is the 
neurotrophic factor BDNF, which was reported to induce the formation of primary dendrites 
in cortical neurons (Dijkhuizen and Ghosh, 2005) and dendritic spine formation and filopodia 
in hippocampal and cortical cultures (McAllister et al., 1995; McAllister et al., 1997; Kumar et 
al., 2005). 
5.1 Roles of TrkB and A2AR activation in Neuronal Maturation 
In the conditions of the present work, I confirmed the existence of A2A and TrkB 
receptors in cortical neurons during the time in culture. Western blot analysis showed an 
increase in TrkB receptor levels, while A2A receptors seem to be nearly constant, although 
present. However, more experiments have to be done to get more accurate conclusions, as in 
the case of A2A receptors, they were reported to increase from E18 onwards (Adén et al., 
2000). The presence of these receptors is associated with their ligand-mediated effects upon 
neuronal maturation. Both BDNF and adenosine, through A2A receptors, have a role upon 
neuronal maturation, since they were responsible for increasing the total neurite length. 
However, the contribution of each receptor to the increase of the total neurite length is not 
the same. While long term treatment of cortical neurons with BDNF mainly increased the 
number of primary neurites, adenosine, through A2A receptor, enhances maximal neurite 
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growth. This effect of A2A receptor activation upon neurite outgrowth has been previously 
described in PC12 cells (Charles et al., 2003), in the human neuroblastoma cell line SH-SY5Y 
and also in primary cultures of striatal neurons (Canals et al., 2005). Consequently, the effect 
of TrkB and A2A receptors activation upon total neurite length is associated to the increase in 
formation of new primary neurites as well as in the elongation of the maximal neurite, which 
most probably will be the axon. In addition, I observed an increase in neuronal branching upon 
TrkB activation with BDNF, as well as when the concentration of A2A receptors agonist was 
slightly increased. Besides the KD value of CGS 21680 for A2A receptor being 15.5 ± 2 nM (Jarvis 
et al., 1989), in previous preliminary experiments performed in the lab, a concentration of A2A 
receptor agonist lower than the KD value was sufficient to induce an increase in neuronal 
branching. This can possibly be explained by the difference in the cellular density of cortical 
cultures used in preliminary experiments and my experiments. In preliminary experiments, 
cultures were plated with 3x104cells/mL, however I could not replicate that, as there was very 
few cells attached to the substratum, and the majority of neurons were death. So, I cultured 
4x104cells/mL, in which the possible raise in neurotrophic factors released from a higher 
number of cells could promote an enhancement in neuronal survival as well as a facilitation of 
neuronal differentiation, mainly in the number of branch points. Thus, a higher density of 
neuronal cells would need higher concentrations of A2A receptor agonist to promote the same 
effect as a lower concentration does in a lower neuronal density culture, possibly due to an 
increase in the concentration threshold needed for CGS 21680 to induce an effect. The effect 
A2A receptor agonist and BDNF upon neuronal branching can be explained by its dependence 
on both the length of maximal neurite and the number of new primary dendrites formed. 
Neurite elongation will make possible to have a higher probability of having more number of 
branch points within it. On the other hand, if more dendrites are formed, there is a higher 
probability of spines and filopodia formation, contributing to a more complex neuronal 
structure 
5.2 Modulation of BDNF actions by A 2A Receptor activation 
As adenosine, through A2A receptor activation, is known to modulate BDNF actions in 
mature neurons (Lee and Chao, 2001; Diógenes et al., 2004; Mojsilovic-Petrovic et al., 2006; 
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Fontinha et al., 2008; Tebano et al., 2008), thus it was explored the hypothesis of adenosine, 
through A2A receptor activation, being involved in the modulation of BDNF-dependent effects 
during neuronal maturation. The A2A receptor antagonist, ZM 241385, did not affect neither 
BDNF-mediated formation of primary neurites nor BDNF-influence upon neuronal branching. 
However, the BDNF action upon the number of branch points seems to be modulated by A2A 
receptor activation, as CGS 21680 was able to enhance this effect and the A2A receptor 
antagonist to attenuate it. One possible explanation for this difference is that BDNF action 
upon formation of primary neurites is not dependent on the modulatory action of A2A 
receptor activation, in opposition with neuronal branching, which corresponds to more 
mature neuronal stages. It was seen by Ji et al., (2005) that the formation of spines and 
filopodia occurs in more mature stages and in these stages a mechanism called the cAMP 
gating is involved in the BDNF-mediated formation of spines and filopodia. When cAMP is 
present BDNF increases the number of spines and filopodia (Ji et al., 2005). As we also know, 
cAMP levels can be elevated by the activation of adenosine A2A receptors (Fredholm et al., 
2001a) and this evidence may explain the fact that CGS 21680 and BDNF added together have 
a more pronounced effect in the number of branch points than they have alone. This cAMP 
gating is only present in mature neurons, not in more immature stages, like when the new 
neurites are formed. 
Such a difference in the effects of A2A receptor modulatory action upon BDNF functions 
in neuronal maturation could be explained by different expression levels of A2A receptor 
during neuronal differentiation and/or its subcellular localization, in relation to TrkB receptors, 
as receptor interaction normally needs physical proximity, in order to signalling pathways to 
interact (Sebastião and Ribeiro, 2000), or even, in a more extreme way, receptor 
heteromerization (Ferré, 2007). On the one hand, regarding protein expression levels, A2A 
receptors were reported to be low or undetectable at E18 and increased until P14 (Adén et al., 
2000), while TrkB also increased during neuronal differentiation. On the other hand, in the 
case of subcellular location, A2A receptors were shown to be mainly present at cortical 
neuronal nerve terminals after six days in culture (Rebola et al., 2005), and TrkB was found in 
the surface of axonal growth cones and dendritic filopodia before synapse formation (Gomes 
et al., 2006). However, their distribution during the different stages of neuronal differentiation 
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could be different, making, consequently, not possible for receptors to interact, in addition to 
the low density of both receptors that could also contribute to a low probability of interaction. 
This situation would change along the time with the expression of more receptors, as 
demonstrated for TrkB, as well as by the possible different subcellular localization during the 
different stages of neuronal differentiation, like it happens to TrkB receptors, which 
increasingly localize into synapses throughout the development (Gomes et al., 2006). Hence, 
at a certain neuronal stage both receptors would be localized at the tip of processes, making 
part of well organized and functional structures that are the lipid rafts, which are 
microdomains in plasma membrane rich in cholesterol and sphingolipids. Lipid rafts have been 
implicated in the regulation of signal transduction in multiple cell types, including neurons, by 
promoting close proximity or segregation of signalling molecules (Fielding and Fielding, 2004; 
Lim and Yin, 2005). Assaife-Lopes et al. (2010) reported that adenosine A2A receptor activation 
increases the levels of TrkB receptors in lipid rafts and potentiates BDNF-induced TrkB 
phosphorylation in these membrane microdomains, therefore facilitating BDNF actions at 
synapses (Assaife-Lopes et al., 2010). In addition, localized signalling through membrane rafts 
was demonstrated to play a role in mediating guidance actions of extracellular cues on growth 
cones of developing axons (Guirland et al., 2004). On the contrary, in immature B cells, the B 
cell Ag receptor (BCR) fails to enter to lipid rafts, in opposition with mature B cells, which may 
contribute to the dramatic difference in the outcome of signalling in mature and immature B 
cells (Sproul et al., 2000). Accordingly, modulatory actions of A2A receptors upon BDNF effects 
in neuronal branching could possibly be explained by the existence of lipid rafts, which at early 
stages of neuronal development could not be yet completely formed, or receptors could not 
be able to enter, so that formation of new primary neurites, and thus dendrites, would not be 
influenced by A2A receptor activation. It was demonstrated, however, that BDNF-induced 
increase in primary dendrites involves TrkB activation in the lipid rafts (Suzuki et al., 2004). 
Regarding A2A receptor, no information is so far available. Therefore, a more deep 
characterization of A2A and TrkB receptors during neuronal differentiation is required and 
fundamental not only in terms of changes in protein expression levels, but also in terms of 
subcellular localization, in order to see if there is any change in receptors localization, mainly 
their relative localization, during neuronal maturation. 
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5.3 Endogenous influence of Adenosine  
The presence of A2A receptor antagonist, ZM 241385, in the extracellular culture 
medium, induced the formation of a shorter maximal neurite, which could be explained by the 
tonically activation of A2A receptor by adenosine; however, the elimination of endogenous 
adenosine by adenosine deaminase did not affect maximal neurite length. One possible 
explanation would be that endogenous adenosine could be, at the same time, tonically 
activating A2A receptor and other adenosine receptor with an opposite role upon maximal 
neurite length. Consequently, the presence of the A2A receptor antagonist could unmask the 
activation of the other adenosine receptor, apart from preventing A2A receptor activation. 
Moreover, the elimination of endogenous adenosine from the external medium would result 
in the absence of any endogenous adenosine receptor activation, thus cancelling out the 
resulting morphological effects. 
Functional evidence indicates that both A1-and A2A subtypes of adenosine receptors can 
coexist in the same nerve terminals (Correia-de-Sá et al., 1991) and that A1 receptors are 
expressed since the last days of gestation in the rat brain neocortex (Rivkees, 1995). Thus, a 
possible candidate is A1 receptor, as its activation has been reported to inhibit neurite 
formation in primary cultures of cortical neurons (Thevananther et al., 2001). It has been 
shown that the stimulation of A2A receptors decreases the binding at A1 receptors in 
hippocampal and striatal synaptosomes and attenuates the ability of A1 receptor agonist to 
inhibit excitability and synaptic transmission in the hippocampus. Interactions between these 
subtypes of receptors, generally activation of A2A receptors, lead to a decrease in the effects 
mediated by A1 receptors (Dixon et al., 1997; O'Kane and Stone, 1998; Lopes et al., 1999). 
While A1 receptor inhibitory responses are enhanced in the presence of A2A receptor 
antagonists, A2A receptor excitatory responses are increased in the presence of A1 receptor 
antagonists (Correia-de-Sá and Ribeiro, 1994). Therefore, the inhibition of A2A receptors would 
enhance A1 receptor inhibitory action, resulting in a shorter maximal neurite growth. 
Elimination of endogenous adenosine receptors agonist would thus relief tonic enhancement 
and inhibition of neurite growth by respectively A2A and A1 receptors activation, canceling the 
influence upon maximal neurite length. 
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Regarding the number of branch points, it seemed that there was a tendency to 
decrease its numbers when the A2A receptor was antagonized or endogenous adenosine was 
removed. This can be explained if A1 receptor does not have any influence upon neuronal 
branching, or even that, another possibility, BDNF actions are modulated by endogenous 
adenosine. As already mentioned, BDNF actions upon neuronal branching seem to be 
influenced by A2A receptor activation, and as endogenous adenosine removal seems to have 
the same effect induced by A2A receptor antagonism. It suggests that endogenous adenosine 
influences BDNF actions upon neuronal branching by just activating A2A receptors. Thus, 
maybe that A1 receptors just influence neurite elongation, or specifically maximal neurite 
elongation, as can be supported by axons being the predominant site of A1 receptor 
expression, in hippocampus (Swanson et al., 1995). 
In order to address if endogenous adenosine has any influence in the actions of TrkB 
and A2A receptors activation, upon neuronal maturation, adenosine was removed when each 
receptor was activated. The removal of endogenous adenosine did not have any effect in the 
actions of A2A receptor activation upon both maximal neurite length and number of branch 
points; however in the last case, it may seem that there is a tendency, when endogenous 
adenosine is eliminated, for activation of A2A receptors induce a more attenuated effect upon 
neuronal branching. At the concentration used (2 times the KD), CGS 21680 could be 
maximally activating A2A receptors, though not fully occupying all the receptors available. 
Consequently, in the case of neurite maximal elongation, elimination of endogenous 
adenosine activation would not influence the effect mediated by A2A receptors. Regarding the 
number of branch points, the possible decrease could be due to inhibition of BDNF actions 
upon this parameter by a different adenosine receptor that was no more activated by 
endogenous adenosine. This would imply that, apart from A2A receptors, BDNF influences 
upon neuronal branching would be also dependent on other adenosine receptor activation. 
Otherwise, a more simple explanation, in the case of CGS 21680 not be maximally activating 
A2A receptors, removal of endogenous adenosine would induce a small decrease in neuronal 
branching. 
In order to understand a little bit more about endogenous adenosine removal upon 
neuronal branching, it is fundamental to know if it affects BDNF action. In this case, while 
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inhibition of endogenous A2A receptor activation just weakly attenuated BDNF-induce of 
neuronal branching, elimination of endogenous adenosine attenuated BDNF actions more 
strongly upon both the formation of primary neurites and branch points. In the case of the 
number of branch points, it could be that A2A receptor activation by endogenous adenosine 
would be modulating BDNF action, given that both removal of adenosine and A2A receptor 
antagonism attenuated BDNF effect upon this parameter. However, that, does not explain the 
fact that endogenous adenosine removal have a stronger effect that the one caused by A2A 
receptor antagonism. Thus, the results suggest that there may be another adenosine receptor 
influencing BDNF action upon neuronal maturation. In the case of number of roots, it does not 
seem that adenosine, through A2A receptor activation, could be influencing BDNF action upon 
the formation of new primary dendrites, as neither its activation by CGS 21680 modified BDNF 
action, nor its inhibition by ZM 241385, influenced this effect. Another adenosine receptor, 
that not the A2A receptor, could be responsible for both differences. Two hypothesis can be 
formulated: (1) an adenosine receptor is tonically activating endogenous adenosine which 
enhances BDNF actions; or (2) the inosine, formed from the metabolisation of adenosine by 
adenosine deaminase, could be activating A3 receptor, which when activated could interfere 
with BDNF-induced formation of primary neurites and branch points. 
In order to test this, it would be necessary to use agonists and antagonists for these 
different adenosine receptors, in order to see which adenosine receptor can be influencing 
BDNF actions. A good adenosine candidate that facilitates BDNF actions could be A2B receptor. 
This adenosine receptor, besides being a low affinity receptor and being poorly spread 
through the brain, but present in the neocortex, is able to stimulate adenylate cyclase, 
inducing cAMP formation, and intracellular Ca2+ transients (Schulte and Fredholm, 2003).The 
signalling mechanisms that control leading process branching are presently unknown, 
although recent work in cerebellar granule cells suggest that this process is modulated by 
intracellular Ca2+ and cAMP levels. Thus, experimentally increasing the concentration of 
intracellular Ca2+ from extracellular sources or internal organelle deposits or stimulating the 
adenylyl cyclase promotes leading process branching, while reducing the intracellular Ca2+ 
concentration or inhibiting PKA decreases its frequency (Kumada et al., 2009). These results 
suggest that guidance cues regulating intracellular Ca2+ and cAMP levels are likely regulators 
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of leading process branching during neuronal migration, which is the case of A2A receptor, and 
possibly A2B receptor. Thus, A2B receptor activation could promote BDNF action upon BDNF 
effect in neuronal branching. Almost nothing is known about this receptor in the brain due to 
the lack of selective receptor agonists (Borea et al., 2009). 
In rodent, the A3 receptor is also a low affinity receptor and is poorly spread in the 
brain, being also expressed in cultured cortical neurons during neuronal development (Dixon 
et al., 1996). It was mostly disseminated throughout the cell body region of cortical neurons 
with a mostly intracellular localization of this receptor (Rebola et al., 2005), although it was 
demonstrated to be present in nerve terminals of cortical neurons (Costenla et al., 2001; Diaz-
Hernandez et al., 2002; Lopes et al., 2003). A3 receptor is known to be responsible for 
decreasing cAMP and thus PKA activity, and, in addition, it can also stimulate Ca2+ transients. 
Attenuation of BDNF effects by addition of ADA can be explained by the formation of inosine, 
which can activate A3 receptors (Jin et al., 1997). As BDNF is dependent on cAMP upon 
neuronal branching and spine formation (Ji et al., 2005; Kumada et al., 2009) and A3 receptor 
induces the decrease of cAMP (Borea et al., 2009), this would result in the attenuation of 
BDNF affects in neuronal maturation. cAMP gates long-term modulation by BDNF upon spine 
density, but it does not gate the number of primary dendrites (Ji et al., 2005), although, 
intracellular Ca2+ levels seems to influence the formation of new primary neurites (Wang and 
Zheng, 1998). Thus, BDNF effect upon formation of new primary neurites could be modulated 
by intracellular Ca2+ induced increase by A3 receptor, which is known to be responsible for 
inducing BDNF collapsing of growth-cones (Wang and Zheng, 1998), contributing thus to an 
attenuation of the number of roots. 
5.4 Signalling Pathways activated by the Adenosine A2A Receptor 
Although a lot is known about BDNF functions in neuronal maturation, very little is 
known regarding A2A receptor functions. Thus, I explored the signalling pathways that could be 
involved in A2A receptor mediated changes in neuronal morphology; BDNF was used as a 
validation control, since there is more information about the signalling pathways that can be 
activated by it. Pharmacological inhibition of the different signalling pathways, PI3K, MAPK, 
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PLC and PKA, was performed, and morphological changes were measured. Results showed 
that BDNF action upon formation of primary neurites was mainly dependent on the activation 
of MAPK, PI3K signalling pathways, with a minor role of PLC and PKA pathways, which is in 
accordance with the results reported by Dijkhuizen and Ghosh (2005). BDNF role in neuronal 
branching was also dependent on the same signalling pathways. In the case of the effects of 
A2A receptor activation on neuronal differentiation, mainly elongation of the maximal neurite, 
there was a dependency on MAPK, PI3K and PLC signalling pathways, with a minor role of 
PKA pathway. However, it seemed that in the case of neuronal branching, the A2A receptor 
effect was dependent on PKA pathway instead of PLC. Although there are common signalling 
pathways activated by different receptors, it is the coordinated interaction with other 
different signalling pathways that allows the appearance of different cellular morphological 
phenotypes. Apart from experiments with pharmacological inhibitors to unravel the signalling 
pathways associated to morphological changes induced by TrkB and A2A receptors activation, 
it would be fundamental to activate each pathway to better understand the function of 
specifically A2A receptor in neuronal differentiation and maturation. 
In the case of BDNF actions upon the formation of new primary dendrites and dendritic 
arborisation, the signalling pathways identified are in accordance with the ones reported by 
Kumar et al. (2005) and Dijkhuizen and Ghosh (2005). Kumar et al. (2005), have reported that 
selective activation of Ras/MAPK pathway leads to increased dendritic complexity without 
affecting primary dendrites, although PI3K/Akt/mTOR pathway increases the number of 
primary dendrites, contributing to a profound alteration of dendritic size and shape (Kumar et 
al., 2005). Whereas the PI3K/Akt/mTOR pathway alone controlled soma and dendritic size, a 
coordinated activation together with the Ras/MAPK signalling pathway was required for 
increasing dendritic complexity, as well as density of dendritic filopodia and spines (Kumar et 
al., 2005). Dijkhuizen and Ghosh (2005) have demonstrated that BDNF can induce rapid 
formation of primary dendrite via activation of PI3K and MAPK pathways. Interestingly, a 
constitutive active form of PI3K, but not MEK, was found to be sufficient to induce primary 
dendrite formation in cortical neurons (Dijkhuizen and Ghosh, 2005). Previous works had 
already shown a role of PI3K and Akt in neurite initiation in PC12 cell line (Tyson et al., 2003), 
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as well as in cultured neuronal cells together with Ras/ERK/MAPK pathway (Rodgers and 
Theibert, 2002). 
Regarding A2A receptor activation and its effect upon neuronal branching, the same 
signalling pathways described for BDNF action seem to be also activated by this adenosine 
receptor. In addition, the PKA pathway seems to be also important for A2A receptor-induced 
increase in the number of branch points. This possibility is supported by the finding that 
stimulating the adenylyl cyclase promotes process branching, while inhibiting PKA decreases it 
(Kumada et al., 2009). Although the effect of A2A receptor activation was similar, the effect 
induced by TrkB receptor activation on neuronal branching at DIC 3 for 5h was much weaker 
than the observed at DIC 7, after four days of treatment. This could be explained by the fact 
that this experiment was performed at DIC 3, a stage of differentiation in which the crosstalk 
between both receptors has not yet been established as in a mature neuron, which in turn 
could be explained by the weak relevance of PKA in BDNF actions upon neuronal maturation. 
These results may support a modulatory action of A2A receptor over BDNF effect upon 
neuronal branching that is going to be established throughout the time window of neuronal 
maturation. To confirm this hypothesis of crosstalk between TrkB and A2A receptors, 
experiments should also be performed at DIC 5, or even DIC 7, in order to see if the 
enhancement of neuronal branching by TrkB receptor activation is becoming more and more 
dependent on PKA signalling pathway. In addition experiments should also be performed in 
the presence of A2A receptor antagonist in order to confirm the A2A receptor modulatory 
action upon BDNF effect in neuronal branching. 
In the case of maximal neurite elongation (which with a high probability corresponds to 
the axon, although it needs confirmation with tau1 staining), it is increased by A2A receptor 
activation and this was dependent on PI3K and MAPK pathways, as well as PLC signalling 
pathway. The coordination of these pathways controls cytoskeleton dynamics, regulating the 
polymerization and depolymerisation of microtubules and microfilaments (Bradke and Dotti, 
1999; da Silva and Dotti, 2002). Several groups reported that local activation of PI3K and 
accumulation of PIP3 at the tip of the immature neurites are important for axon specification 
and elongation (Shi et al., 2003; Menager et al., 2004). PI3K is located upstream of various 
regulators of both actin and microtubule dynamics. PI3K activates Akt (also called protein 
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kinase B) (Scheid and Woodgett, 2001), which leads to neuronal polarization, and, when 
overexpressed by phosphorylated, Akt leads to the formation of multiple axons (Jiang et al., 
2005). Activated Akt phosphorylates GSK-3β, which is constitutively active, at Ser-9 and 
inactivates its kinase activity (Grimes and Jope, 2001). Decreased activity of GSK-3β is required 
for neuronal polarization (Jiang et al., 2005; Yoshimura et al., 2005), axon growth (Zhou et al., 
2004) and also branching (Garrido et al., 2007). Collapsin response mediator protein (CRMP)-2 
has been identified as a substrate of GSK-3β (Cole et al., 2004; Yoshimura et al., 2005). CRMP-
2 accumulates at the distal part of a growing axon, which overexpression induces multiple 
axons, and the inhibition of CRMP-2 impairs axon formation (Inagaki et al., 2001). It is known 
that CRMP-2 interacts with tubulin heterodimers and promotes microtubule assembly in vitro 
(Fukata et al., 2002). GSK3β is also responsible for regulating the affinity of MAPs to 
microtubules (Goold et al., 1999; Trivedi et al., 2005). Consistent with the complex effects on 
MAPs, GSK-3β can either support or inhibit axonal growth depending on the extent of its 
inhibition (Kim et al., 2006). PI3K activity, highly localized to the tip of the newly specified axon 
of stage 3 neurons, is also essential for mPar3/mPar6/aPKC complex function required for 
axon development. (Shi et al., 2003). 
In the case of PLC pathway, it can induce raise in intracellular Ca2+. Intracellular Ca2+ 
can regulate neurite elongation and growth cone motility (Mattson et al., 1988), whereas 
suppressing Ca2+ transients accelerates axon extension, Ca2+ influx slows otherwise rapid 
axonal growth (Gomez and Spitzer, 1999). 
BDNF has been recently associated to neuronal polarization, being responsible for axon 
specification, through a mechanism dependent on LKB1 (PAR4) (Asada et al., 2007; Barnes et 
al., 2007; Shelly et al., 2007). As a result, when applied to the whole medium, BDNF is 
responsible for inducing the formation of multiple axons (Shelly et al., 2007). In cultured 
control conditions, the induction of axon-specification is considered to be a stochastic 
phenomenon, because cultured neurons are in an uniformed environment, and thus, in the 
absence of extracellular cues, an internal polarization program might occur (Craig and Banker, 
1994). When present an external signal that is able to induce neuronal polarity is present, a 
multiaxonal neuron will develop. Nevertheless, at DIC 3, cultured neurons have already 
become polarized, and thus, activation of TrkB receptors by treatment with BDNF, will not 
Discussion 
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influence, nor cause, the formation of multiple axons. In order to be sure about this, it would 
be very important to stain neurons for tau1 protein, in order to see if cells have a single axon, 
or multiple axons. 
The action of signalling pathways such as PI3K/Akt/mTOR, or MAPK upon the growth 
and branching of dendrites, can result from the regulation of global and/or local protein 
translation, and as a convergence point for multiple signalling pathways. mTOR could play a 
central role in the control of dendrite growth and branching during development and in 
response to activity (Jaworski et al., 2005). Both PI3K and mTOR, as well as MAPK, activation 
leads to phosphorylation of eIF4E and to translation initiation (for a review, see Gingras et al., 
1999). 
Intracellular mechanisms that help to enhance neurite and axon outgrowth evidently 
require reorganization of cytoskeleton, including actin filaments and microtubules (Geraldo 
and Gordon-Weeks, 2009). Hence, it is fundamental to explore the signalling mechanisms 
regarding each pathway triggered by A2A receptor and TrkB in cultured cortical cultures, in 
terms of sequence signalling molecules steps, which may culminate in the regulation of 
cytoskeletal molecules. In addition, it will be necessary to evaluate the regulation of the 
formation of the first synapses and if synaptic proteins such as NMDA and synaptophysin are 
regulated by activation of these receptors. 
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6 CONCLUSION 
Neurons are highly polarized cells which are formed by a one thin long process, 
responsible to transmit information, the axon, and several shorter processes that receive 
information, the dendrites. In order to form a functional mature neuron, external signalling 
cues are fundamental to orientate processes growth and establishment of synapses. 
In this work I demonstrated that both A2A and TrkB receptors have a role in neuronal 
development and differentiation. While the TrkB receptor is responsible for enhancing the 
formation of new primary dendrites, the A2A receptor is responsible for the elongation of the 
maximal neurite. Both receptors promote dendrite arborisation. Although A2A receptors 
promote BDNF action in mature neurons, these results suggest that in early stages of neuronal 
development, this adenosine receptor does not affect BDNF actions upon the formation of 
new dendrites. Nevertheless, A2A receptor seems to influence BDNF actions upon dendritic 
arborization, what suggests that throughout neuronal development A2A receptors might start 
to influence BDNF actions upon neuronal maturation. Hence, it seems that BDNF actions are 
not dependent from A2A receptor activation upon neuronal differentiation, but can be 
dependent in what concerns neuronal maturation. Besides new primary dendrites formation 
induced by BDNF is not dependent on A2A receptor activation, results suggest however that it 
can be dependent on the action of another adenosine receptor. The same may occur to BDNF 
effects upon dendritic branching. In addition, endogenous adenosine is important to tonically 
activate A2A receptors, and promote maximal neurite elongation and dendritic branching. 
The study of signalling pathways involved in the change of neuronal morphological 
characteristics, demonstrated that BDNF actions upon both number of roots and branch 
points are mainly dependent on MAPK and PI3K signalling pathways, with a minor role of PLC 
and PKA pathways, which are in accordance with data already published. Like BDNF, A2A 
receptors are mainly dependent on MAPK and PI3K, both in neuronal branching and in the 
elongation of maximal neurite. However, in the case of elongation of the maximal neurite, 
PLCpathway seemed to be also important, while in the case of neuronal branching, instead of 
PLC, the PKA pathway seems to be relevant. 
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